{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T12:16:52Z","timestamp":1789474612777,"version":"build-2803163510"},"reference-count":259,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s10787-025-01850-7","type":"journal-article","created":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T05:58:18Z","timestamp":1753509498000},"page":"4205-4235","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["New insights on pharmacological potential of montelukast: a comprehensive review"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-3367-613X","authenticated-orcid":false,"given":"Karan","family":"Goel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhirendra","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5702-0932","authenticated-orcid":false,"given":"Rajat","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2889-0004","authenticated-orcid":false,"given":"Seema","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0692-7002","authenticated-orcid":false,"given":"Sukhbir","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neelam","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2980-7791","authenticated-orcid":false,"given":"Sumeet","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,26]]},"reference":[{"issue":"3","key":"1850_CR1","doi-asserted-by":"publisher","first-page":"e14469","DOI":"10.1016\/j.heliyon.2023.e14469","volume":"9","author":"RSG Aashli","year":"2023","unstructured":"Aashli RSG, Siva KB, Prashanthi K, Murthy HCA (2023) Fabricating transdermal film formulations of montelukast sodium with improved chemical stability and extended drug release. Heliyon 9(3):e14469. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e14469","journal-title":"Heliyon"},{"issue":"4","key":"1850_CR2","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3109\/15412555.2015.1046041","volume":"13","author":"KHS Abdel","year":"2016","unstructured":"Abdel KHS. (2016) Montelukast versus dexamethasone treatment in a guinea pig model of chronic pulmonary neutrophilic inflammation. COPD: J Chronic Obstructive Pulmonary Dis 13(4):455\u2013463. https:\/\/doi.org\/10.3109\/15412555.2015.1046041","journal-title":"COPD: J Chronic Obstructive Pulmonary Dis"},{"issue":"9","key":"1850_CR3","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s00011-021-01492-9","volume":"70","author":"SA Abdelhady","year":"2021","unstructured":"Abdelhady SA, Ali MA, Al-Shafie TA, Abdelmawgoud EM, Yacout DM, El-Mas MM (2021) Montelukast potentiates the antiinflammatory effect of NSAIDs in the rat paw formalin model and simultaneously minimizes the risk of gastric damage. Inflammation Res 70(9):981\u2013992. https:\/\/doi.org\/10.1007\/s00011-021-01492-9","journal-title":"Inflammation Res"},{"issue":"4","key":"1850_CR4","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s00210-013-0949-x","volume":"387","author":"IT Abdel-Raheem","year":"2014","unstructured":"Abdel-Raheem IT, Khedr NF (2014) Renoprotective effects of montelukast, a cysteinyl leukotriene receptor antagonist, against methotrexate-induced kidney damage in rats. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 387(4):341\u2013353. https:\/\/doi.org\/10.1007\/s00210-013-0949-x","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"issue":"1","key":"1850_CR5","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s10571-020-00841-2","volume":"41","author":"LA Abdelzaher","year":"2021","unstructured":"Abdelzaher LA, Hussein OA, Ashry IEM (2021) The novel potential therapeutic utility of montelukast in alleviating autistic behavior induced by early postnatal administration of thimerosal in mice. Cellular Mole Neurobiol 41(1):129\u2013150. https:\/\/doi.org\/10.1007\/s10571-020-00841-2","journal-title":"Cellular Mole Neurobiol"},{"issue":"8","key":"1850_CR6","doi-asserted-by":"publisher","first-page":"914","DOI":"10.3390\/ph15080914","volume":"15","author":"WY Abdelzaher","year":"2022","unstructured":"Abdelzaher WY, Mostafa-Hedeab G, Bahaa HA, Mahran A, Atef Fawzy M, Abdel Hafez SMN, Welson NN, Rofaeil RR (2022) Leukotriene receptor antagonist, montelukast ameliorates L-NAME-induced pre-eclampsia in rats through suppressing the IL-6\/Jak2\/STAT3 signaling pathway. Pharmaceuticals 15(8):914. https:\/\/doi.org\/10.3390\/ph15080914","journal-title":"Pharmaceuticals"},{"issue":"1","key":"1850_CR7","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ejphar.2007.05.040","volume":"571","author":"A Adamek","year":"2007","unstructured":"Adamek A, Jung S, Dienesch C, Laser M, Ertl G, Bauersachs J, Frantz S (2007) Role of 5-lipoxygenase in myocardial ischemia-reperfusion injury in mice. Euro J Pharmacol 571(1):51\u201354. https:\/\/doi.org\/10.1016\/j.ejphar.2007.05.040","journal-title":"Euro J Pharmacol"},{"issue":"1","key":"1850_CR8","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/1749-8090-6-81","volume":"6","author":"FG Al-Amran","year":"2011","unstructured":"Al-Amran FG, Hadi NR, Hashim AM (2011) Leukotriene biosynthesis inhibition ameliorates acute lung injury following hemorrhagic shock in rats. J Cardiothoracic Surg 6(1):81. https:\/\/doi.org\/10.1186\/1749-8090-6-81","journal-title":"J Cardiothoracic Surg"},{"issue":"1","key":"1850_CR9","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1080\/19336918.2021.1911472","volume":"15","author":"B Alday-Parejo","year":"2021","unstructured":"Alday-Parejo B, Ghimire K, Coquoz O, Albisetti GW, Tam\u00f2 L, Zaric J, Stalin J, R\u00fcegg C (2021) MAGI1 localizes to mature focal adhesion and modulates endothelial cell adhesion, migration and angiogenesis. Cell Adhesion Migration 15(1):126\u2013139. https:\/\/doi.org\/10.1080\/19336918.2021.1911472","journal-title":"Cell Adhesion Migration"},{"issue":"10","key":"1850_CR10","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1080\/00207454.2020.1769618","volume":"131","author":"E Alizamani","year":"2021","unstructured":"Alizamani E, Ghorbanzadeh B, Naserzadeh R, Mansouri MT (2021) Montelukast, a cysteinyl leukotriene receptor antagonist, exerts local antinociception in animal model of pain through the L-arginine\/nitric oxide\/cyclic GMP\/K ATP channel pathway and PPAR\u03b3 receptors. Int J Neurosci 131(10):1004\u20131011. https:\/\/doi.org\/10.1080\/00207454.2020.1769618","journal-title":"Int J Neurosci"},{"key":"1850_CR11","doi-asserted-by":"publisher","DOI":"10.4103\/atm.atm_248_23","author":"MS Al-Moamary","year":"2023","unstructured":"Al-Moamary MS, Alhaider SA, Allehebi R, Idrees MM, Zeitouni MO, Al Ghobain MO, Alanazi AF, Al-Harbi AS, Yousef AA, Alorainy HS, Al-Hajjaj MS (2023) The Saudi initiative for asthma\u20142024 update: guidelines for the diagnosis and management of asthma in adults and children. Ann Thoracic Med. https:\/\/doi.org\/10.4103\/atm.atm_248_23","journal-title":"Ann Thoracic Med"},{"issue":"6","key":"1850_CR12","doi-asserted-by":"publisher","first-page":"819","DOI":"10.25122\/jml-2021-0269","volume":"15","author":"ZA Alnfakh","year":"2022","unstructured":"Alnfakh ZA, Al-Mudhafar DH, Al-Nafakh RT, Jasim AE, Hadi NR (2022) The anti-inflammatory and antioxidant effects of Montelukast on lung sepsis in adult mice. J Med Life 15(6):819\u2013827. https:\/\/doi.org\/10.25122\/jml-2021-0269","journal-title":"J Med Life"},{"issue":"9","key":"1850_CR13","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.3390\/ph15091147","volume":"15","author":"BM Alomair","year":"2022","unstructured":"Alomair BM, Al-kuraishy HM, Al-Gareeb AI, Al-Hamash SM, De Waard M, Sabatier J-M, Saad HM, El-Saber Batiha G (2022) Montelukast and acute coronary syndrome: the endowed drug. Pharmaceuticals 15(9):1147. https:\/\/doi.org\/10.3390\/ph15091147","journal-title":"Pharmaceuticals"},{"issue":"8","key":"1850_CR14","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1002\/jbmr.4867","volume":"38","author":"F Amadeu de Oliveira","year":"2023","unstructured":"Amadeu de Oliveira F, Tokuhara CK, Veeriah V, Domezi JP, Santesso MR, Cestari TM, Ventura TMO, Matos AA, Dion\u00edsio T, Ferreira MR, Ortiz RC, Duarte MAH, Buzalaf MAR, Ponce JB, Sorgi CA, Faccioli LH, Buzalaf CP, de Oliveira RC (2023) The multifarious functions of leukotrienes in bone metabolism. J Bone Mineral Res 38(8):1135\u20131153. https:\/\/doi.org\/10.1002\/jbmr.4867","journal-title":"J Bone Mineral Res"},{"key":"1850_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4684-5700-1_3","author":"R Ardaillou","year":"1989","unstructured":"Ardaillou R, Baud L, Sraer J (1989) Lipoxygenase products and their functions in glomeruli. Renal Eicosanoids. https:\/\/doi.org\/10.1007\/978-1-4684-5700-1_3","journal-title":"Renal Eicosanoids"},{"issue":"3","key":"1850_CR16","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1002\/jcph.1738","volume":"61","author":"DH Arnold","year":"2021","unstructured":"Arnold DH, Van Driest SL, Reiss TF, King JC, Akers WS (2021) Pilot study of peak plasma concentration after high-dose oral montelukast in children with acute asthma exacerbations. J Clin Pharmacol 61(3):360\u2013367. https:\/\/doi.org\/10.1002\/jcph.1738","journal-title":"J Clin Pharmacol"},{"key":"1850_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.867261","author":"F Artru","year":"2022","unstructured":"Artru F, McPhail MJW, Triantafyllou E, Trovato FM (2022) Lipids in liver failure syndromes: a focus on eicosanoids. specialized pro-resolving lipid mediators and lysophospholipids. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2022.867261","journal-title":"Front Immunol"},{"issue":"1","key":"1850_CR18","doi-asserted-by":"publisher","first-page":"120","DOI":"10.4103\/2008-7802.193097","volume":"7","author":"A Aslani","year":"2016","unstructured":"Aslani A, Beigi M (2016) Design, formulation, and physicochemical evaluation of montelukast orally disintegrating tablet. Int J Preventive Med 7(1):120. https:\/\/doi.org\/10.4103\/2008-7802.193097","journal-title":"Int J Preventive Med"},{"key":"1850_CR19","doi-asserted-by":"publisher","DOI":"10.1093\/toxres\/tfaf007","author":"RK Attarbashee","year":"2024","unstructured":"Attarbashee RK, Hamodat HF, Mammdoh JK, Ridha-Salman H (2024) The Possible effect of Bosentan on the methotrexate-induced salivary gland changes in male rats: histological and immunohistochemical study. Toxicol Res. https:\/\/doi.org\/10.1093\/toxres\/tfaf007","journal-title":"Toxicol Res"},{"issue":"12","key":"1850_CR20","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.3390\/molecules25122871","volume":"25","author":"SA Audat","year":"2020","unstructured":"Audat SA, Al-Shari NA, Al-Oudat BA, Bryant-Friedrich A, Bedi MF, Zayed AL, Al-Balas QA (2020) Identification of human leukotriene A4 hydrolase inhibitors using structure-based pharmacophore modeling and molecular docking. Molecules 25(12):2871. https:\/\/doi.org\/10.3390\/molecules25122871","journal-title":"Molecules"},{"issue":"15","key":"1850_CR21","doi-asserted-by":"publisher","first-page":"3551","DOI":"10.1111\/bph.12665","volume":"171","author":"M B\u00e4ck","year":"2014","unstructured":"B\u00e4ck M, Powell WS, Dahl\u00e9n S, Drazen JM, Evans JF, Serhan CN, Shimizu T, Yokomizo T, Rovati GE (2014) Update on leukotriene, lipoxin and oxoeicosanoid receptors: IUPHAR Review 7. British J Pharmacol 171(15):3551\u20133574. https:\/\/doi.org\/10.1111\/bph.12665","journal-title":"British J Pharmacol"},{"key":"1850_CR22","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/978-94-007-7678-4_42","volume-title":"Biomarkers in cardiovascular disease","author":"M B\u00e4ck","year":"2016","unstructured":"B\u00e4ck M, Labat C, Stanke-Labesque F, Benetos A (2016) Leukotrienes as biomarkers of cardiovascular disease. Biomarkers in cardiovascular disease. Springer Netherlands, pp 449\u2013466"},{"issue":"11","key":"1850_CR23","first-page":"1282","volume":"25","author":"SK Balani","year":"1997","unstructured":"Balani SK, Xu X, Pratha V, Koss MA, Amin RD, Dufresne C, Miller RR, Arison BH, Doss GA, Chiba M, Freeman A, Holland SD, Schwartz JI, Lasseter KC, Gertz BJ, Isenberg JI, Rogers JD, Lin JH, Baillie TA (1997) Metabolic profiles of montelukast sodium (Singulair), a potent cysteinyl leukotriene1 receptor antagonist, in human plasma and bile. Drug Metab Disposition: Biol Fate Chem 25(11):1282\u20131287","journal-title":"Drug Metab Disposition: Biol Fate Chem"},{"issue":"5","key":"1850_CR24","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41573-023-00670-0","volume":"22","author":"TH Baryakova","year":"2023","unstructured":"Baryakova TH, Pogostin BH, Langer R, McHugh KJ (2023) Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems. Nature Rev Drug Discov 22(5):387\u2013409. https:\/\/doi.org\/10.1038\/s41573-023-00670-0","journal-title":"Nature Rev Drug Discov"},{"key":"1850_CR25","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.alcohol.2023.05.008","volume":"113","author":"MA Behmanesh","year":"2023","unstructured":"Behmanesh MA, Rasekhian A, Kiani F, Dehghandoost M, Dezfuli DA, Ghorbanzadeh B (2023) The nitric oxide-cyclic GMP-KATP channels pathway contributes to the effects of montelukast against gastric damage induced by ethanol. Alcohol 113:33\u201340. https:\/\/doi.org\/10.1016\/j.alcohol.2023.05.008","journal-title":"Alcohol"},{"issue":"2","key":"1850_CR26","doi-asserted-by":"publisher","first-page":"4","DOI":"10.14341\/osteo12930","volume":"24","author":"ZHE Belaya","year":"2021","unstructured":"Belaya ZHE, Belova KYU, Biryukova EV, Dedov II, Dzeranova LK, Drapkina OM, Dreval AV, Dubovitskaya TA, Dudinskaya EN, Ershova OB, Zagorodniy NV, Ilyukhina OB, Kanis JA, Kryukova IV, Lesnyak OM, Mamedova EO, Marchenkova LA, Melnichenkova GA, Nikankina LV, NYakushevskaya OV (2021) Federal clinical guidelines for diagnosis, treatment and prevention of osteoporosis. Osteoporosis Bone Dis 24(2):4\u201347. https:\/\/doi.org\/10.14341\/osteo12930","journal-title":"Osteoporosis Bone Dis"},{"key":"1850_CR27","doi-asserted-by":"publisher","DOI":"10.2147\/CIA.S35977","author":"V Bellia","year":"2013","unstructured":"Bellia V, Battaglia S, Benfante A, Scichilone N (2013) Safety and efficacy of montelukast as adjunctive therapy for treatment of asthma in elderly patients. Clin Interventions Aging. https:\/\/doi.org\/10.2147\/CIA.S35977","journal-title":"Clin Interventions Aging"},{"issue":"4","key":"1850_CR28","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/j.athoracsur.2008.06.037","volume":"86","author":"M Berman","year":"2008","unstructured":"Berman M, Tsui S, Vuylsteke A, Snell A, Colah S, Latimer R, Hall R, Arrowsmith JE, Kneeshaw J, Klein AA, Jenkins DP (2008) Successful extracorporeal membrane oxygenation support after pulmonary thromboendarterectomy. Ann Thoracic Surg 86(4):1261\u20131267. https:\/\/doi.org\/10.1016\/j.athoracsur.2008.06.037","journal-title":"Ann Thoracic Surg"},{"issue":"1","key":"1850_CR29","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s00280-011-1692-y","volume":"69","author":"A Beytur","year":"2012","unstructured":"Beytur A, Ciftci O, Oguz F, Oguzturk H, Y\u0131lmaz F (2012a) Montelukast attenuates side effects of cisplatin including testicular, spermatological, and hormonal damage in male rats. Cancer Chemother Pharmacol 69(1):207\u2013213. https:\/\/doi.org\/10.1007\/s00280-011-1692-y","journal-title":"Cancer Chemother Pharmacol"},{"issue":"3","key":"1850_CR30","doi-asserted-by":"publisher","first-page":"343","DOI":"10.3109\/0886022X.2011.647305","volume":"34","author":"A Beytur","year":"2012","unstructured":"Beytur A, K\u00f6se E, Sarihan ME, Sapmaz HI, Dogan Z, Cetin A, Vardi N, Turkoz Y, Ekinci N (2012b) Beneficial effects of montelukast against cisplatin-induced acute renal damage in rats. Ren Fail 34(3):343\u2013349. https:\/\/doi.org\/10.3109\/0886022X.2011.647305","journal-title":"Ren Fail"},{"issue":"14","key":"1850_CR31","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.3390\/ijerph16142560","volume":"16","author":"RG Biringer","year":"2019","unstructured":"Biringer RG (2019) The role of eicosanoids in alzheimer\u2019s disease. Int J Environ Res Public Health 16(14):2560. https:\/\/doi.org\/10.3390\/ijerph16142560","journal-title":"Int J Environ Res Public Health"},{"issue":"2","key":"1850_CR32","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.chest.2017.08.029","volume":"153","author":"CA Bonham","year":"2018","unstructured":"Bonham CA, Patterson KC, Strek ME (2018) Asthma outcomes and management during pregnancy. Chest 153(2):515\u2013527. https:\/\/doi.org\/10.1016\/j.chest.2017.08.029","journal-title":"Chest"},{"issue":"8","key":"1850_CR33","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1016\/S0021-9258(17)30120-5","volume":"254","author":"P Borgeat","year":"1979","unstructured":"Borgeat P, Samuelsson B (1979) Transformation of arachidonic acid by rabbit polymorphonuclear leukocytes. Formation of a novel dihydroxyeicosatetraenoic acid. J Biol Chem 254(8):2643\u20132646. https:\/\/doi.org\/10.1016\/S0021-9258(17)30120-5","journal-title":"J Biol Chem"},{"issue":"7","key":"1850_CR34","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.3899\/jrheum.090153","volume":"37","author":"J Bourr\u00e9-Tessier","year":"2010","unstructured":"Bourr\u00e9-Tessier J, Haraoui B (2010) Methotrexate drug interactions in the treatment of rheumatoid arthritis: a systematic review. J Rheumatol 37(7):1416\u20131421. https:\/\/doi.org\/10.3899\/jrheum.090153","journal-title":"J Rheumatol"},{"key":"1850_CR35","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1002\/cphy.c120027","volume-title":"Comprehensive physiology","author":"JL Boyer","year":"2013","unstructured":"Boyer JL (2013) Bile formation and secretion. Comprehensive physiology. Wiley, pp 1035\u20131078"},{"issue":"4","key":"1850_CR36","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.prrv.2011.05.009","volume":"12","author":"PLP Brand","year":"2011","unstructured":"Brand PLP (2011) Inhaled corticosteroids should be the first line of treatment for children with asthma. Paediatric Respiratory Rev 12(4):245\u2013249. https:\/\/doi.org\/10.1016\/j.prrv.2011.05.009","journal-title":"Paediatric Respiratory Rev"},{"issue":"6","key":"1850_CR37","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1111\/j.1526-4610.2004.446006.x","volume":"44","author":"JL Brandes","year":"2004","unstructured":"Brandes JL, Visser WH, Farmer MV, Schuhl AL, Malbecq W, Vrijens F, Lines CR, Reines SA (2004) Montelukast for migraine prophylaxis: a randomized, double-blind, placebo-controlled study. Headache: J Head Face Pain 44(6):581\u2013586. https:\/\/doi.org\/10.1111\/j.1526-4610.2004.446006.x","journal-title":"Headache: J Head Face Pain"},{"issue":"11","key":"1850_CR38","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.3390\/ijms18112353","volume":"18","author":"C Brewer","year":"2017","unstructured":"Brewer C, Chen T (2017) Hepatotoxicity of herbal supplements mediated by modulation of cytochrome P450. Int J Mole Sci 18(11):2353. https:\/\/doi.org\/10.3390\/ijms18112353","journal-title":"Int J Mole Sci"},{"issue":"51","key":"1850_CR39","doi-asserted-by":"publisher","first-page":"35314","DOI":"10.1074\/jbc.M114.577825","volume":"289","author":"AN Bukiya","year":"2014","unstructured":"Bukiya AN, McMillan J, Liu J, Shivakumar B, Parrill AL, Dopico AM (2014) Activation of calcium- and voltage-gated potassium channels of large conductance by leukotriene B4. J Biol Chem 289(51):35314\u201335325. https:\/\/doi.org\/10.1074\/jbc.M114.577825","journal-title":"J Biol Chem"},{"key":"1850_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.784214","author":"M Camera","year":"2022","unstructured":"Camera M, Canzano P, Brambilla M, Rovati GE (2022) Montelukast inhibits platelet activation induced by plasma from COVID-19 patients. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2022.784214","journal-title":"Front Pharmacol"},{"issue":"12","key":"1850_CR41","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1124\/dmd.115.065763","volume":"43","author":"JDO Cardoso","year":"2015","unstructured":"Cardoso JDO, Oliveira RV, Lu JBL, Desta Z (2015) In vitro metabolism of montelukast by cytochrome P450s and UDP-glucuronosyltransferases. Drug Metab Disposition 43(12):1905\u20131916. https:\/\/doi.org\/10.1124\/dmd.115.065763","journal-title":"Drug Metab Disposition"},{"key":"1850_CR42","doi-asserted-by":"publisher","DOI":"10.1093\/eurpub\/ckv176.224","author":"C Cavero-Carbonell","year":"2015","unstructured":"Cavero-Carbonell C, Vinkel-Hansen A, de Jong VDBL, Rabanaque-Hern\u00e1ndez M, Martos-Jim\u00e9nez C, Zurriaga O, Garne E (2015) Montelukast during pregnancy and congenital anomalies. A cross-sectional study in Denmark. Euro J Public Health. https:\/\/doi.org\/10.1093\/eurpub\/ckv176.224","journal-title":"Euro J Public Health"},{"issue":"6","key":"1850_CR43","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1002\/bdra.23621","volume":"109","author":"C Cavero-Carbonell","year":"2017","unstructured":"Cavero-Carbonell C, Vinkel-Hansen A, Rabanque-Hern\u00e1ndez MJ, Martos C, Garne E (2017) Fetal exposure to montelukast and congenital anomalies: a population based study in Denmark. Birth Defects Res 109(6):452\u2013459. https:\/\/doi.org\/10.1002\/bdra.23621","journal-title":"Birth Defects Res"},{"issue":"4","key":"1850_CR44","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.amjsurg.2013.03.003","volume":"206","author":"A Celik","year":"2013","unstructured":"Celik A, Ergun E, Koksal N, Celik AS, Altinli E, Uzun MA, Eroglu E, Kemik A (2013) Effects of montelukast on the healing of ischemic colon anastomoses. Am J Surg 206(4):502\u2013508. https:\/\/doi.org\/10.1016\/j.amjsurg.2013.03.003","journal-title":"Am J Surg"},{"issue":"1","key":"1850_CR45","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3109\/10731190903495785","volume":"38","author":"Z Chen","year":"2010","unstructured":"Chen Z, Lv H, Jiang J (2010) LTB4 can stimulate human osteoclast differentiation dependent of RANKL. Arti Cells, Blood Substitutes, Biotechnol 38(1):52\u201356. https:\/\/doi.org\/10.3109\/10731190903495785","journal-title":"Arti Cells, Blood Substitutes, Biotechnol"},{"key":"1850_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.03079","author":"Y Chen","year":"2020","unstructured":"Chen Y, Li Y, Wang X, Zou P (2020) Montelukast, an anti-asthmatic drug inhibits zika virus infection by disrupting viral integrity. Front Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2019.03079","journal-title":"Front Microbiol"},{"key":"1850_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.877125","author":"H-C Chen","year":"2022","unstructured":"Chen H-C, Chiou H-YC, Tsai M-L, Chen S-C, Lin M-H, Chuang T-C, Hung C-H, Kuo C-H (2022a) Effects of montelukast on arsenic-induced epithelial-mesenchymal transition and the role of reactive oxygen species production in human bronchial epithelial cells. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2022.877125","journal-title":"Front Pharmacol"},{"issue":"5","key":"1850_CR48","doi-asserted-by":"publisher","first-page":"861","DOI":"10.3390\/v14050861","volume":"14","author":"Y Chen","year":"2022","unstructured":"Chen Y, Wang X, Shi H, Zou P (2022b) Montelukast inhibits HCoV-OC43 infection as a viral inactivator. Viruses 14(5):861. https:\/\/doi.org\/10.3390\/v14050861","journal-title":"Viruses"},{"issue":"3","key":"1850_CR49","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1023\/A:1016056912698","volume":"13","author":"H Cheng","year":"1996","unstructured":"Cheng H, Leff JA, Amin R, Gertz BJ, De Smet M, Noonan N, Rogers JD, Malbecq W, Meisner D, Somers G (1996) Pharmacokinetics, bioavailability, and safety of montelukast sodium (MK-0476) in healthy males and females. Pharm Res 13(3):445\u2013448. https:\/\/doi.org\/10.1023\/A:1016056912698","journal-title":"Pharm Res"},{"issue":"9","key":"1850_CR50","first-page":"1022","volume":"25","author":"M Chiba","year":"1997","unstructured":"Chiba M, Xu X, Nishime JA, Balani SK, Lin JH (1997) Hepatic microsomal metabolism of montelukast, a potent leukotriene D4 receptor antagonist, in humans. Drug Metab Disposition: Biol Fate Chem 25(9):1022\u20131031","journal-title":"Drug Metab Disposition: Biol Fate Chem"},{"key":"1850_CR51","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.neuroscience.2012.10.009","volume":"228","author":"VP Chou","year":"2013","unstructured":"Chou VP, Holman TR, Manning-Bog AB (2013) Differential contribution of lipoxygenase isozymes to nigrostriatal vulnerability. Neuroscience 228:73\u201382. https:\/\/doi.org\/10.1016\/j.neuroscience.2012.10.009","journal-title":"Neuroscience"},{"issue":"2","key":"1850_CR52","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.acthis.2008.04.006","volume":"111","author":"E \u00c7ikler","year":"2009","unstructured":"\u00c7ikler E, Ersoy Y, \u00c7etinel \u015e, Ercan F (2009) The leukotriene d4 receptor antagonist, montelukast, inhibits mast cell degranulation in the dermis induced by water avoidance stress. Acta Histochem 111(2):112\u2013118. https:\/\/doi.org\/10.1016\/j.acthis.2008.04.006","journal-title":"Acta Histochem"},{"key":"1850_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/2432958","volume":"2017","author":"F Colazzo","year":"2017","unstructured":"Colazzo F, Gelosa P, Tremoli E, Sironi L, Castiglioni L (2017) Role of the cysteinyl leukotrienes in the pathogenesis and progression of cardiovascular diseases. Mediators Inflammation 2017:1\u201313. https:\/\/doi.org\/10.1155\/2017\/2432958","journal-title":"Mediators Inflammation"},{"issue":"2","key":"1850_CR54","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1302\/2046-3758.22.2000066","volume":"2","author":"JA Cottrell","year":"2013","unstructured":"Cottrell JA, Keshav V, Mitchell A, O\u2019Connor JP (2013) Local inhibition of 5-lipoxygenase enhances bone formation in a rat model. Bone Joint Res 2(2):41\u201350. https:\/\/doi.org\/10.1302\/2046-3758.22.2000066","journal-title":"Bone Joint Res"},{"issue":"3\u20134","key":"1850_CR55","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.prostaglandins.2008.10.004","volume":"88","author":"M Cuciureanu","year":"2009","unstructured":"Cuciureanu M, C\u0103runtu I-D, P\u0103duraru O, Stoica B, Jerca L, Crauciuc E, Nechifor M (2009) The protective effect of montelukast sodium on carbon tetrachloride induced hepatopathy in rat. Prostaglandins Other Lipid Mediators 88(3\u20134):82\u201388. https:\/\/doi.org\/10.1016\/j.prostaglandins.2008.10.004","journal-title":"Prostaglandins Other Lipid Mediators"},{"issue":"1","key":"1850_CR56","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12903-022-02083-8","volume":"22","author":"FL da Silva","year":"2022","unstructured":"da Silva FL, de Campos CLG, de Oliveira FM, Nelson-Filho P, da Silva LAB, Segato RAB, Faccioli LH, Paula-Silva FWG (2022) Leukotriene B4 loaded in microspheres regulate the expression of genes related to odontoblastic differentiation and biomineralization by dental pulp stem cells. BMC Oral Health 22(1):45. https:\/\/doi.org\/10.1186\/s12903-022-02083-8","journal-title":"BMC Oral Health"},{"issue":"1","key":"1850_CR57","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jss.2008.02.052","volume":"153","author":"G Daglar","year":"2009","unstructured":"Daglar G, Karaca T, Yuksek YN, Gozalan U, Akbiyik F, Sokmensuer C, Gurel B, Kama NA (2009) Effect of montelukast and MK-886 on hepatic ischemia-reperfusion injury in rats. J Surg Res 153(1):31\u201338. https:\/\/doi.org\/10.1016\/j.jss.2008.02.052","journal-title":"J Surg Res"},{"key":"1850_CR58","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1089\/bfm.2016.0162","volume":"12","author":"P Datta","year":"2017","unstructured":"Datta P, Rewers-Felkins K, Baker T, Hale TW (2017) Transfer of montelukast into human milk during lactation. Breastfeeding Med\u202f: off J Acad Breastfeeding Med 12:54\u201357. https:\/\/doi.org\/10.1089\/bfm.2016.0162","journal-title":"Breastfeeding Med : off J Acad Breastfeeding Med"},{"issue":"1","key":"1850_CR59","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1254\/jphs.FP0070122","volume":"105","author":"GO Dengiz","year":"2007","unstructured":"Dengiz GO, Odabasoglu F, Halici Z, Cadirci E, Suleyman H (2007) Gastroprotective and antioxidant effects of montelukast on indomethacin-induced gastric ulcer in rats. J Pharmacol Sci 105(1):94\u2013102. https:\/\/doi.org\/10.1254\/jphs.FP0070122","journal-title":"J Pharmacol Sci"},{"issue":"6","key":"1850_CR60","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1586\/eci.09.62","volume":"5","author":"Z Diamant","year":"2009","unstructured":"Diamant Z, Mantzouranis E, Bjermer L (2009) Montelukast in the treatment of asthma and beyond. Expert Rev Clin Immunol 5(6):639\u2013658. https:\/\/doi.org\/10.1586\/eci.09.62","journal-title":"Expert Rev Clin Immunol"},{"issue":"3","key":"1850_CR61","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1515\/cipms-2015-0066","volume":"28","author":"L Dobrek","year":"2015","unstructured":"Dobrek L, Skowron B, Baranowska A, Thor PJ (2015) The influence of montelukast on the autonomic nervous system activity in rats with cyclophosphamide-induced hemorrhagic cystitis. Curr Issues Pharm Med Sci 28(3):170\u2013175. https:\/\/doi.org\/10.1515\/cipms-2015-0066","journal-title":"Curr Issues Pharm Med Sci"},{"key":"1850_CR62","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.intimp.2018.04.042","volume":"61","author":"H Dong","year":"2018","unstructured":"Dong H, Liu F, Ma F, Xu L, Pang L, Li X, Liu B, Wang L (2018) Montelukast inhibits inflammatory response in rheumatoid arthritis fibroblast-like synoviocytes. Int Immunopharmacol 61:215\u2013221. https:\/\/doi.org\/10.1016\/j.intimp.2018.04.042","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"1850_CR63","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.trsl.2015.08.004","volume":"167","author":"AL Durham","year":"2016","unstructured":"Durham AL, Caramori G, Chung KF, Adcock IM (2016) Targeted anti-inflammatory therapeutics in asthma and chronic obstructive lung disease. Trans Res 167(1):192\u2013203. https:\/\/doi.org\/10.1016\/j.trsl.2015.08.004","journal-title":"Trans Res"},{"issue":"1","key":"1850_CR64","doi-asserted-by":"publisher","first-page":"10112","DOI":"10.1038\/ncomms10112","volume":"6","author":"E Dvash","year":"2015","unstructured":"Dvash E, Har-Tal M, Barak S, Meir O, Rubinstein M (2015) Leukotriene C4 is the major trigger of stress-induced oxidative DNA damage. Nature Commun 6(1):10112. https:\/\/doi.org\/10.1038\/ncomms10112","journal-title":"Nature Commun"},{"issue":"1","key":"1850_CR65","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s12876-021-01854-x","volume":"21","author":"EA El-Alali","year":"2021","unstructured":"El-Alali EA, Abukhiran IM, Alhmoud TZ (2021) Successful use of montelukast in eosinophilic gastroenteritis: a case report and a literature review. BMC Gastroenterol 21(1):279. https:\/\/doi.org\/10.1186\/s12876-021-01854-x","journal-title":"BMC Gastroenterol"},{"key":"1850_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.120707","volume":"304","author":"DH El-Kashef","year":"2022","unstructured":"El-Kashef DH, Zaghloul RA (2022) Ameliorative effect of montelukast against carbon tetrachloride-induced hepatotoxicity: targeting NLRP3 inflammasome pathway. Life Sci 304:120707. https:\/\/doi.org\/10.1016\/j.lfs.2022.120707","journal-title":"Life Sci"},{"issue":"1","key":"1850_CR67","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s43066-021-00152-1","volume":"11","author":"A El-Shayeb","year":"2021","unstructured":"El-Shayeb A, El-Mallah S, Deghady A, El-Hewely S, Elwazzan D (2021) Validity of serum leukotriene B4 as a marker of decompensated liver cirrhosis in chronic HCV patients: leukotriene B4 in decompensated liver cirrhosis. Egyptian Liver J 11(1):84. https:\/\/doi.org\/10.1186\/s43066-021-00152-1","journal-title":"Egyptian Liver J"},{"issue":"11","key":"1850_CR68","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1177\/0748233713485884","volume":"31","author":"AE-DE El-Sisi","year":"2015","unstructured":"El-Sisi AE-DE, Sokar SS, Salem TA, Abu Risha SE (2015) Role of cysteinyl leukotriene receptor-1 antagonists in treatment of experimentally induced mammary tumor. Toxicol Ind Health 31(11):1024\u20131036. https:\/\/doi.org\/10.1177\/0748233713485884","journal-title":"Toxicol Ind Health"},{"issue":"3","key":"1850_CR69","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.3390\/app13031273","volume":"13","author":"M Espada-S\u00e1nchez","year":"2023","unstructured":"Espada-S\u00e1nchez M, de S\u00e1enz SMR, Mart\u00edn-Astorga MDC, Lebr\u00f3n-Mart\u00edn C, Delgado MJ, Eguiluz-Gracia I, Rond\u00f3n C, Mayorga C, Torres MJ, Aranda CJ, Ca\u00f1as JA (2023) Diagnosis and treatment in asthma and allergic rhinitis: past, present, and future. Appl Sci 13(3):1273. https:\/\/doi.org\/10.3390\/app13031273","journal-title":"Appl Sci"},{"issue":"1","key":"1850_CR70","doi-asserted-by":"publisher","first-page":"52","DOI":"10.21608\/rpbs.2018.5920","volume":"1","author":"S Essawy","year":"2018","unstructured":"Essawy S, Abdelfatah A, Abo-El-Matty D (2018) Pretreatment with montelukast and curcumin protect against etoposide-induced testicular toxicity in rats: role of oxidation, inflammation and apoptosis. Records Pharm Biomed Sci 1(1):52\u201369. https:\/\/doi.org\/10.21608\/rpbs.2018.5920","journal-title":"Records Pharm Biomed Sci"},{"issue":"1","key":"1850_CR71","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1186\/s12931-024-03078-5","volume":"25","author":"V Fainardi","year":"2024","unstructured":"Fainardi V, Grandinetti R, Mussi N, Rossi A, Masetti M, Giudice A, Pilloni S, Deolmi M, Ramundo G, Alboresi S, Bergamini BM, Bergomi A, Bersini MT, Biserna L, Bottau P, Corinaldesi E, Crestani S, De Paulis N, Fontijn S, Esposito S (2024) Exercise-induced bronchoconstriction in children: delphi study and consensus document about definition and epidemiology, diagnostic work-up, treatment, and follow-up. Respiratory Res 25(1):445. https:\/\/doi.org\/10.1186\/s12931-024-03078-5","journal-title":"Respiratory Res"},{"issue":"6","key":"1850_CR72","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/cga.12581","volume":"64","author":"A Fareed","year":"2024","unstructured":"Fareed A, Siblini D, Vaid R, Farhat H, Rida A, Moradeyo A, Khan MA (2024) Montelukast use in pregnancy: a systematic review and meta-analysis of maternal and fetal outcomes in asthma treatment. Congenit Anom 64(6):220\u2013227. https:\/\/doi.org\/10.1111\/cga.12581","journal-title":"Congenit Anom"},{"issue":"11","key":"1850_CR73","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1089\/neu.2009.0877","volume":"26","author":"S Farias","year":"2009","unstructured":"Farias S, Frey LC, Murphy RC, Heidenreich KA (2009) Injury-related production of cysteinyl leukotrienes contributes to brain damage following experimental traumatic brain injury. J Neurotrauma 26(11):1977\u20131986. https:\/\/doi.org\/10.1089\/neu.2009.0877","journal-title":"J Neurotrauma"},{"key":"1850_CR74","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15770","author":"N Fazelzadeh Haghighi","year":"2022","unstructured":"Fazelzadeh Haghighi N, Dastgheib L, Saki N, Alipour S, Ranjbar S (2022) Montelukast as an effective adjuvant in the treatment of moderate acne vulgaris. Dermatol Ther. https:\/\/doi.org\/10.1111\/dth.15770","journal-title":"Dermatol Ther"},{"issue":"3","key":"1850_CR75","doi-asserted-by":"publisher","first-page":"7894","DOI":"10.1080\/21655979.2022.2051689","volume":"13","author":"Z Fei","year":"2022","unstructured":"Fei Z, Zhang L, Wang L, Jiang H, Peng A (2022) Montelukast ameliorated pemetrexed-induced cytotoxicity in hepatocytes by mitigating endoplasmic reticulum (ER) stress and nucleotide oligomerization domain-like receptor protein 3 (NLRP3) activation. Bioengineered 13(3):7894\u20137903. https:\/\/doi.org\/10.1080\/21655979.2022.2051689","journal-title":"Bioengineered"},{"key":"1850_CR76","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00515","author":"LR Filgueiras","year":"2015","unstructured":"Filgueiras LR, Serezani CH, Jancar S (2015) Leukotriene B4 as a potential therapeutic target for the treatment of metabolic disorders. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2015.00515","journal-title":"Front Immunol"},{"issue":"5","key":"1850_CR77","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1124\/dmd.110.037689","volume":"39","author":"AM Filppula","year":"2011","unstructured":"Filppula AM, Laitila J, Neuvonen PJ, Backman JT (2011) Reevaluation of the microsomal metabolism of montelukast: major contribution by CYP2C8 at clinically relevant concentrations. Drug Metab Disposition 39(5):904\u2013911. https:\/\/doi.org\/10.1124\/dmd.110.037689","journal-title":"Drug Metab Disposition"},{"key":"1850_CR78","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.phrs.2015.02.001","volume":"94","author":"J Fleck","year":"2015","unstructured":"Fleck J, Marafiga JR, Jesse AC, Ribeiro LR, Rambo LM, Mello CF (2015) Montelukast potentiates the anticonvulsant effect of phenobarbital in mice: an isobolographic analysis. Pharmacol Res 94:34\u201341. https:\/\/doi.org\/10.1016\/j.phrs.2015.02.001","journal-title":"Pharmacol Res"},{"key":"1850_CR79","doi-asserted-by":"publisher","DOI":"10.1590\/1414-431X20155031","author":"J Fleck","year":"2016","unstructured":"Fleck J, Temp FR, Marafiga JR, Jesse AC, Milanesi LH, Rambo LM, Mello CF (2016) Montelukast reduces seizures in pentylenetetrazol-kindled mice. Brazilian J Med Biol Res. https:\/\/doi.org\/10.1590\/1414-431X20155031","journal-title":"Brazilian J Med Biol Res"},{"issue":"2","key":"1850_CR80","doi-asserted-by":"publisher","first-page":"270","DOI":"10.3390\/pharmaceutics13020270","volume":"13","author":"LM Fuhr","year":"2021","unstructured":"Fuhr LM, Marok FZ, Hanke N, Selzer D, Lehr T (2021) Pharmacokinetics of the CYP3A4 and CYP2B6 inducer carbamazepine and its drug-drug interaction potential: a physiologically based pharmacokinetic modeling approach. Pharmaceutics 13(2):270. https:\/\/doi.org\/10.3390\/pharmaceutics13020270","journal-title":"Pharmaceutics"},{"key":"1850_CR81","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.theriogenology.2021.07.021","volume":"173","author":"V Ganjiani","year":"2021","unstructured":"Ganjiani V, Ahmadi N, Divar MR, Sharifiyazdi H, Meimandi-Parizi A (2021) Protective effects of crocin on testicular torsion\/detorsion in rats. Theriogenology 173:241\u2013248. https:\/\/doi.org\/10.1016\/j.theriogenology.2021.07.021","journal-title":"Theriogenology"},{"issue":"1","key":"1850_CR82","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.atherosclerosis.2008.11.012","volume":"205","author":"S Ge","year":"2009","unstructured":"Ge S, Zhou G, Cheng S, Liu D, Xu J, Xu G, Liu X (2009) Anti-atherogenic effects of montelukast associated with reduced MCP-1 expression in a rabbit carotid balloon injury model. Atherosclerosis 205(1):74\u201379. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2008.11.012","journal-title":"Atherosclerosis"},{"key":"1850_CR83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/3454212","volume":"2017","author":"P Gelosa","year":"2017","unstructured":"Gelosa P, Colazzo F, Tremoli E, Sironi L, Castiglioni L (2017) Cysteinyl leukotrienes as potential pharmacological targets for cerebral diseases. Mediators Inflammation 2017:1\u201315. https:\/\/doi.org\/10.1155\/2017\/3454212","journal-title":"Mediators Inflammation"},{"key":"1850_CR84","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1011141","author":"B Ghorbanzadeh","year":"2022","unstructured":"Ghorbanzadeh B, Behmanesh MA, Mahmoudinejad R, Zamaniyan M, Ekhtiar S, Paridar Y (2022) The effect of montelukast, a leukotriene receptor antagonist, on the acetic acid-induced model of colitis in rats: Involvement of NO-cGMP-KATP channels pathway. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2022.1011141","journal-title":"Front Pharmacol"},{"key":"1850_CR85","doi-asserted-by":"publisher","first-page":"e530s","DOI":"10.6061\/clinics\/2018\/e530s","volume":"73","author":"RN Gomes","year":"2018","unstructured":"Gomes RN, Felipe da Costa S, Colquhoun A (2018) Eicosanoids and cancer. Clinics 73:e530s. https:\/\/doi.org\/10.6061\/clinics\/2018\/e530s","journal-title":"Clinics"},{"issue":"3","key":"1850_CR86","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s11096-020-01160-8","volume":"43","author":"B Grinde","year":"2021","unstructured":"Grinde B, Schirmer H, Eggen AE, Aigner L, Engdahl B (2021) A possible effect of montelukast on neurological aging examined by the use of register data. Int J Clin Pharm 43(3):541\u2013548. https:\/\/doi.org\/10.1007\/s11096-020-01160-8","journal-title":"Int J Clin Pharm"},{"issue":"7","key":"1850_CR87","doi-asserted-by":"publisher","first-page":"2680","DOI":"10.1172\/JCI97945","volume":"128","author":"JZ Haeggstr\u00f6m","year":"2018","unstructured":"Haeggstr\u00f6m JZ (2018) Leukotriene biosynthetic enzymes as therapeutic targets. J Clin Investig 128(7):2680\u20132690. https:\/\/doi.org\/10.1172\/JCI97945","journal-title":"J Clin Investig"},{"issue":"10","key":"1850_CR88","doi-asserted-by":"publisher","first-page":"5866","DOI":"10.1021\/cr200246d","volume":"111","author":"JZ Haeggstr\u00f6m","year":"2011","unstructured":"Haeggstr\u00f6m JZ, Funk CD (2011) Lipoxygenase and leukotriene pathways: biochemistry, biology, and roles in disease. Chem Rev 111(10):5866\u20135898. https:\/\/doi.org\/10.1021\/cr200246d","journal-title":"Chem Rev"},{"issue":"1","key":"1850_CR89","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.bbrc.2010.03.140","volume":"396","author":"JZ Haeggstr\u00f6m","year":"2010","unstructured":"Haeggstr\u00f6m JZ, Rinaldo-Matthis A, Wheelock CE, Wetterholm A (2010) Advances in eicosanoid research, novel therapeutic implications. Biochem Biophys Res Commun 396(1):135\u2013139. https:\/\/doi.org\/10.1016\/j.bbrc.2010.03.140","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"1850_CR90","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1080\/01480545.2020.1730885","volume":"45","author":"HM Hafez","year":"2022","unstructured":"Hafez HM, Hassanein H (2022) Montelukast ameliorates doxorubicin-induced cardiotoxicity via modulation of p-glycoprotein and inhibition of ROS-mediated TNF-\u03b1\/NF-\u03baB pathways. Drug Chem Toxicol 45(2):548\u2013559. https:\/\/doi.org\/10.1080\/01480545.2020.1730885","journal-title":"Drug Chem Toxicol"},{"issue":"11","key":"1850_CR91","doi-asserted-by":"publisher","first-page":"3845","DOI":"10.1096\/fj.201600620R","volume":"30","author":"M Halle","year":"2016","unstructured":"Halle M, Christersdottir T, Bf\u00e4ck M (2016) Chronic adventitial inflammation, vasa vasorum expansion, and 5-lipoxygenase up-regulation in irradiated arteries from cancer survivors. FASEB J 30(11):3845\u20133852. https:\/\/doi.org\/10.1096\/fj.201600620R","journal-title":"FASEB J"},{"issue":"2","key":"1850_CR92","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/imm.13308","volume":"163","author":"B Han","year":"2021","unstructured":"Han B, Zhang Y, Ye Z, Xiao Y, Rasouli J, Wu W, Ye S, Guo X, Zhu L, Rostami A, Wang L, Zhang Y, Li X (2021) Montelukast alleviates inflammation in experimental autoimmune encephalomyelitis by altering Th17 differentiation in a mouse model. Immunology 163(2):185\u2013200. https:\/\/doi.org\/10.1111\/imm.13308","journal-title":"Immunology"},{"issue":"5","key":"1850_CR93","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/s41433-021-01484-3","volume":"36","author":"A Hardas","year":"2022","unstructured":"Hardas A, Singh N, Mohanty A, Sahu SK (2022) Efficacy of montelukast in preventing seasonal recurrence of vernal keratoconjunctivitis in children. Eye 36(5):978\u2013984. https:\/\/doi.org\/10.1038\/s41433-021-01484-3","journal-title":"Eye"},{"issue":"7","key":"1850_CR94","doi-asserted-by":"publisher","first-page":"3513","DOI":"10.3390\/ijms23073513","volume":"23","author":"C Harvey","year":"2022","unstructured":"Harvey C, Weldon S, Elborn S, Downey DG, Taggart C (2022) The effect of CFTR modulators on airway infection in cystic fibrosis. Int J Mole Sci 23(7):3513. https:\/\/doi.org\/10.3390\/ijms23073513","journal-title":"Int J Mole Sci"},{"issue":"1\u20133","key":"1850_CR95","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.ejphar.2012.03.018","volume":"683","author":"MM Helmy","year":"2012","unstructured":"Helmy MM, El-Gowelli HM (2012) Montelukast abrogates rhabdomyolysis-induced acute renal failure via rectifying detrimental changes in antioxidant profile and systemic cytokines and apoptotic factors production. Euro J Pharmacol 683(1\u20133):294\u2013300. https:\/\/doi.org\/10.1016\/j.ejphar.2012.03.018","journal-title":"Euro J Pharmacol"},{"issue":"10","key":"1850_CR96","first-page":"675","volume":"51","author":"AA Hemmati","year":"2013","unstructured":"Hemmati AA, Ghorbanzadeh B, Behmanesh MA (2013) Potentiation of indomethacin-induced anti-inflammatory response by montelukast in formalin-induced inflammation in rats. Acta Med Iran 51(10):675\u2013680","journal-title":"Acta Med Iran"},{"key":"1850_CR97","doi-asserted-by":"publisher","DOI":"10.5812\/jjnpp.65046","author":"AA Hemmati","year":"2017","unstructured":"Hemmati AA, Olapour S, Najafzadeh Varzi H, Khodayar MJ, Dianat M, Mohammadian B, Yaghooti H (2017) The evaluation of the ameliorative effect of montelukast against arsenic trioxide-induced cardiotoxicity in rats. Jundishapur J Nat Pharm Prod. https:\/\/doi.org\/10.5812\/jjnpp.65046","journal-title":"Jundishapur J Nat Pharm Prod"},{"issue":"1","key":"1850_CR98","doi-asserted-by":"publisher","first-page":"18286","DOI":"10.1038\/srep18286","volume":"5","author":"KJ Herbst-Robinson","year":"2015","unstructured":"Herbst-Robinson KJ, Liu L, James M, Yao Y, Xie SX, Brunden KR (2015) Inflammatory eicosanoids increase amyloid precursor protein expression via activation of multiple neuronal receptors. Sci Rep 5(1):18286. https:\/\/doi.org\/10.1038\/srep18286","journal-title":"Sci Rep"},{"issue":"2","key":"1850_CR99","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1080\/17425255.2020.1718107","volume":"16","author":"I Hern\u00e1ndez Lozano","year":"2020","unstructured":"Hern\u00e1ndez Lozano I, Langer O (2020) Use of imaging to assess the activity of hepatic transporters. Expert Opinion Drug Metab Toxicol 16(2):149\u2013164. https:\/\/doi.org\/10.1080\/17425255.2020.1718107","journal-title":"Expert Opinion Drug Metab Toxicol"},{"issue":"18","key":"1850_CR100","doi-asserted-by":"publisher","first-page":"4366","DOI":"10.1039\/C8AN00772A","volume":"143","author":"NM Hosny","year":"2018","unstructured":"Hosny NM, Atia NN, El-Gizawy SM, Badary DM, Hareedy MS (2018) Innovative HPTLC method with fluorescence detection for assessment of febuxostat\u2013montelukast combination and study of their protective effects against gouty arthritis. Analyst 143(18):4366\u20134378. https:\/\/doi.org\/10.1039\/C8AN00772A","journal-title":"Analyst"},{"key":"1850_CR101","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.biopha.2018.07.033","volume":"106","author":"M Hoxha","year":"2018","unstructured":"Hoxha M, Lewis-Mikhael A-M, Bueno-Cavanillas A (2018) Potential role of leukotriene receptor antagonists in reducing cardiovascular and cerbrovascular risk: a systematic review of human clinical trials and in vivo animal studies. Biomed Pharmacother 106:956\u2013965. https:\/\/doi.org\/10.1016\/j.biopha.2018.07.033","journal-title":"Biomed Pharmacother"},{"key":"1850_CR102","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.611561","author":"M Hoxha","year":"2021","unstructured":"Hoxha M, Tedesco CC, Quaglin S, Malaj V, Pustina L, Capra V, Evans JF, Sala A, Rovati GE (2021) Montelukast use decreases cardiovascular events in asthmatics. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2020.611561","journal-title":"Front Pharmacol"},{"issue":"6","key":"1850_CR103","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/S0091-6749(99)70006-0","volume":"104","author":"D Ihaku","year":"1999","unstructured":"Ihaku D, Cameron L, Suzuki M, Molet S, Martin J, Hamid Q (1999) Montelukast, a leukotriene receptor antagonist, inhibits the late airway response to antigen, airway eosinophilia, and IL-5\u2013expressing cells in Brown Norway rats. J Allergy Clin Immunol 104(6):1147\u20131154. https:\/\/doi.org\/10.1016\/S0091-6749(99)70006-0","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"1850_CR104","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.jaci.2011.11.052","volume":"129","author":"E Ingelsson","year":"2012","unstructured":"Ingelsson E, Yin L, B\u00e4ck M (2012) Nationwide cohort study of the leukotriene receptor antagonist montelukast and incident or recurrent cardiovascular disease. J Allergy Clin Immunol 129(3):702-707.e2. https:\/\/doi.org\/10.1016\/j.jaci.2011.11.052","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"1850_CR105","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1002\/cpt.947","volume":"104","author":"MK Itkonen","year":"2018","unstructured":"Itkonen MK, Tornio A, Filppula AM, Neuvonen M, Neuvonen PJ, Niemi M, Backman JT (2018) Clopidogrel but not prasugrel significantly inhibits the CYP2C8-mediated metabolism of montelukast in humans. Clin Pharmacol Ther 104(3):495\u2013504. https:\/\/doi.org\/10.1002\/cpt.947","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"1850_CR106","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1097\/WNR.0000000000000740","volume":"28","author":"H Jang","year":"2017","unstructured":"Jang H, Kim S, Lee JM, Oh Y-S, Park SM, Kim SR (2017) Montelukast treatment protects nigral dopaminergic neurons against microglial activation in the 6-hydroxydopamine mouse model of Parkinson\u2019s disease. NeuroReport 28(5):242\u2013249. https:\/\/doi.org\/10.1097\/WNR.0000000000000740","journal-title":"NeuroReport"},{"key":"1850_CR107","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.858855","author":"HY Jang","year":"2022","unstructured":"Jang HY, Kim I-W, Oh JM (2022) Cysteinyl leukotriene receptor antagonists associated with a decreased incidence of cancer: a retrospective cohort study. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2022.858855","journal-title":"Front Oncol"},{"issue":"4","key":"1850_CR108","doi-asserted-by":"publisher","first-page":"305","DOI":"10.4168\/aair.2016.8.4.305","volume":"8","author":"YH Jeon","year":"2016","unstructured":"Jeon YH, Min TK, Yang H-J, Pyun BY (2016) A double-blind, randomized, crossover study to compare the effectiveness of montelukast on atopic dermatitis in Korean Children. Allergy, Asthma Immunol Res 8(4):305. https:\/\/doi.org\/10.4168\/aair.2016.8.4.305","journal-title":"Allergy, Asthma Immunol Res"},{"issue":"4","key":"1850_CR109","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1080\/10837450.2018.1514523","volume":"24","author":"T Jullaphant","year":"2019","unstructured":"Jullaphant T, Nakpeng T, Srichana T (2019) Montelukast nasal spray: formulation development and in vitro evaluation. Pharm Develop Technol 24(4):494\u2013503. https:\/\/doi.org\/10.1080\/10837450.2018.1514523","journal-title":"Pharm Develop Technol"},{"issue":"1","key":"1850_CR110","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.neuroscience.2010.08.039","volume":"171","author":"H Kalonia","year":"2010","unstructured":"Kalonia H, Kumar P, Kumar A, Nehru B (2010) Protective effect of montelukast against quinolinic acid\/malonic acid induced neurotoxicity: possible behavioral, biochemical, mitochondrial and tumor necrosis factor-\u03b1 level alterations in rats. Neuroscience 171(1):284\u2013299. https:\/\/doi.org\/10.1016\/j.neuroscience.2010.08.039","journal-title":"Neuroscience"},{"key":"1850_CR111","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.neuropharm.2013.06.014","volume":"73","author":"K-H Kang","year":"2013","unstructured":"Kang K-H, Liou H-H, Hour M-J, Liou H-C, Fu W-M (2013) Protection of dopaminergic neurons by 5-lipoxygenase inhibitor. Neuropharmacology 73:380\u2013387. https:\/\/doi.org\/10.1016\/j.neuropharm.2013.06.014","journal-title":"Neuropharmacology"},{"key":"1850_CR112","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2018.9179","author":"J Kang","year":"2018","unstructured":"Kang J, Lim H, Lee D, Yim M (2018) Montelukast inhibits RANKL-induced osteoclast formation and bone loss via CysLTR1 and P2Y12. Mole Med Rep. https:\/\/doi.org\/10.3892\/mmr.2018.9179","journal-title":"Mole Med Rep"},{"key":"1850_CR113","doi-asserted-by":"publisher","DOI":"10.18502\/jpc.v12i2.16190","author":"J Kansagra","year":"2024","unstructured":"Kansagra J, Dubey V, Kheni D, Sureja V (2024) 5-lipoxygenase: the therapeutically unexplored target for bone health. J Pharm Care. https:\/\/doi.org\/10.18502\/jpc.v12i2.16190","journal-title":"J Pharm Care"},{"issue":"2","key":"1850_CR114","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/0952-3278(90)90158-H","volume":"40","author":"N Kawada","year":"1990","unstructured":"Kawada N, Mizoguchi Y, Sakagami Y, Kobayashi K, Yamamoto S, Morisawa S (1990) Changes in leukotrienes and prostaglandins in the liver tissue of rats in the experimental massive hepatic cell necrosis model. Prostaglandins Leukot Essent Fatty Acids 40(2):149\u2013155. https:\/\/doi.org\/10.1016\/0952-3278(90)90158-H","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"1850_CR115","doi-asserted-by":"publisher","DOI":"10.1155\/2009\/145071","author":"PK Keith","year":"2009","unstructured":"Keith PK, Koch C, Djandji M, Bouchard J, Psaradellis E, Sampalis JS, Schellenberg RR, McIvor RA (2009) Montelukast as add-on therapy with inhaled corticosteroids or inhaled corticosteroids and long-acting beta-2-agonists in the management of patients diagnosed with asthma and concurrent allergic rhinitis (The RADAR Trial). Canadian Respiratory J. https:\/\/doi.org\/10.1155\/2009\/145071","journal-title":"Canadian Respiratory J"},{"issue":"9","key":"1850_CR116","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/S0006-3223(98)00210-8","volume":"44","author":"JM Kent","year":"1998","unstructured":"Kent JM, Coplan JD, Gorman JM (1998) Clinical utility of the selective serotonin reuptake inhibitors in the spectrum of anxiety. Biol Psychiatry 44(9):812\u2013824. https:\/\/doi.org\/10.1016\/S0006-3223(98)00210-8","journal-title":"Biol Psychiatry"},{"issue":"5","key":"1850_CR117","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1002\/jmv.27552","volume":"94","author":"B Kerget","year":"2022","unstructured":"Kerget B, Kerget F, Ayd\u0131n M, Kara\u015fahin \u00d6 (2022) Effect of montelukast therapy on clinical course, pulmonary function, and mortality in patients with COVID-19. J Med Virol 94(5):1950\u20131958. https:\/\/doi.org\/10.1002\/jmv.27552","journal-title":"J Med Virol"},{"issue":"4","key":"1850_CR118","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1080\/02770903.2021.1881967","volume":"59","author":"AR Khan","year":"2022","unstructured":"Khan AR, Misdary C, Yegya-Raman N, Kim S, Narayanan N, Siddiqui S, Salgame P, Radbel J, Groote FD, Michel C, Mehnert J, Hernandez C, Braciale T, Malhotra J, Gentile MA, Jabbour SK (2022) Montelukast in hospitalized patients diagnosed with COVID-19. J Asthma 59(4):780\u2013786. https:\/\/doi.org\/10.1080\/02770903.2021.1881967","journal-title":"J Asthma"},{"issue":"1","key":"1850_CR119","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s10787-021-00907-7","volume":"30","author":"P Khodabakhsh","year":"2022","unstructured":"Khodabakhsh P, Khoie N, Dehpour A-R, Abdollahi A, Ghazi-Khansari M, Shafaroodi H (2022) Montelukast suppresses the development of irritable bowel syndrome phenotype possibly through modulating NF-\u03baB signaling in an experimental model. Inflammopharmacology 30(1):313\u2013325. https:\/\/doi.org\/10.1007\/s10787-021-00907-7","journal-title":"Inflammopharmacology"},{"issue":"10","key":"1850_CR120","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1139\/cjpp-2014-0191","volume":"92","author":"AE Khodir","year":"2014","unstructured":"Khodir AE, Ghoneim HA, Rahim MA, Suddek GM (2014) Montelukast reduces sepsis-induced lung and renal injury in rats. Canadian J Physiol Pharmacol 92(10):839\u2013847. https:\/\/doi.org\/10.1139\/cjpp-2014-0191","journal-title":"Canadian J Physiol Pharmacol"},{"issue":"4","key":"1850_CR121","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1177\/0960327115591372","volume":"35","author":"A Khodir","year":"2016","unstructured":"Khodir A, Ghoneim H, Rahim M, Suddek G (2016) Montelukast attenuates lipopolysaccharide-induced cardiac injury in rats. Human Exp Toxicol 35(4):388\u2013397. https:\/\/doi.org\/10.1177\/0960327115591372","journal-title":"Human Exp Toxicol"},{"issue":"10","key":"1850_CR122","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1111\/cea.14196","volume":"52","author":"D Khokhar","year":"2022","unstructured":"Khokhar D, Marella S, Idelman G, Chang JW, Chehade M, Hogan SP (2022) Eosinophilic esophagitis: immune mechanisms and therapeutic targets. Clin Exp Allergy 52(10):1142\u20131156. https:\/\/doi.org\/10.1111\/cea.14196","journal-title":"Clin Exp Allergy"},{"issue":"1","key":"1850_CR123","doi-asserted-by":"publisher","DOI":"10.1136\/bmjpo-2023-002483","volume":"8","author":"JW Kim","year":"2024","unstructured":"Kim JW, Kim M, Seo MS, Shin J-Y (2024) Risk of neuropsychiatric adverse events associated with montelukast use in children and adolescents: a population-based case-crossover study. BMJ Paediatrics Open 8(1):e002483. https:\/\/doi.org\/10.1136\/bmjpo-2023-002483","journal-title":"BMJ Paediatrics Open"},{"issue":"3","key":"1850_CR124","doi-asserted-by":"publisher","first-page":"S171","DOI":"10.1067\/mai.2000.109424","volume":"106","author":"B Knorr","year":"2000","unstructured":"Knorr B, Holland S, Rogers JD, Nguyen HH, Reiss TF (2000) Montelukast adult (10-mg film-coated tablet) and pediatric (5-mg chewable tablet) dose selections. J Allergy Clin Immunol 106(3):S171\u2013S178. https:\/\/doi.org\/10.1067\/mai.2000.109424","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"1850_CR125","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1046\/j.1472-9725.2001.t01-1-00011.x","volume":"1","author":"B Knorr","year":"2001","unstructured":"Knorr B, Holland S, Schwartz J, Rogers JD, Reiss TF (2001) Clinical pharmacology of montelukast. Clin Exp Allergy Rev 1(3):254\u2013260. https:\/\/doi.org\/10.1046\/j.1472-9725.2001.t01-1-00011.x","journal-title":"Clin Exp Allergy Rev"},{"issue":"6","key":"1850_CR126","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1515\/tjb-2024-0111","volume":"49","author":"V K\u00f6l\u00fck\u00e7\u00fc","year":"2024","unstructured":"K\u00f6l\u00fck\u00e7\u00fc V, Unsal V, Katar M, Balta MG, Tapar H, Karaman T, Karaman S, F\u0131rat F, Yal\u00e7\u0131n K, Gevrek F, Kuyucu YE (2024) Possible protective effect of remifentanil against testicular ischemia-reperfusion injury. Turkish J Biochem 49(6):801\u2013809. https:\/\/doi.org\/10.1515\/tjb-2024-0111","journal-title":"Turkish J Biochem"},{"issue":"4","key":"1850_CR127","first-page":"503","volume":"16","author":"E Kose","year":"2012","unstructured":"Kose E, Beytur A, Dogan Z, Ekincioglu Z, Vardi N, Cinar K, Turkoz Y, Soysal H, Ekinci N (2012a) The effects of montelukast against amikacin-induced acute renal damage. Euro Rev Med Pharmacol Sci 16(4):503\u2013511","journal-title":"Euro Rev Med Pharmacol Sci"},{"key":"1850_CR128","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1100\/2012\/987508","volume":"2012","author":"E Kose","year":"2012","unstructured":"Kose E, Sapmaz HI, Sarihan E, Vardi N, Turkoz Y, Ekinci N (2012b) Beneficial effects of montelukast against methotrexate-induced liver toxicity: a biochemical and histological study. Sci World J 2012:1\u20136. https:\/\/doi.org\/10.1100\/2012\/987508","journal-title":"Sci World J"},{"issue":"5","key":"1850_CR129","doi-asserted-by":"publisher","first-page":"564","DOI":"10.18203\/2319-2003.ijbcp20211654","volume":"10","author":"PV Kumar","year":"2021","unstructured":"Kumar PV (2021) Licofelone in osteoarthritis: is this the awaited drug? a systematic review. Int J Basic Clin Pharmacol 10(5):564. https:\/\/doi.org\/10.18203\/2319-2003.ijbcp20211654","journal-title":"Int J Basic Clin Pharmacol"},{"issue":"2","key":"1850_CR130","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1159\/000375434","volume":"31","author":"S Kuru","year":"2015","unstructured":"Kuru S, Kismet K, Barlas AM, Tuncal S, Celepli P, Surer H, Ogus E, Ertas E (2015) The effect of montelukast on liver damage in an experimental obstructive jaundice model. Visceral Med 31(2):131\u2013138. https:\/\/doi.org\/10.1159\/000375434","journal-title":"Visceral Med"},{"issue":"1","key":"1850_CR131","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/1749-8090-8-64","volume":"8","author":"G Lafci","year":"2013","unstructured":"Lafci G, Gedik HS, Korkmaz K, Erdem H, Cicek OF, Nacar OA, Yildirim L, Kaya E, Ankarali H (2013) Efficacy of iloprost and montelukast combination on spinal cord ischemia\/reperfusion injury in a rat model. J Cardiothoracic Surg 8(1):64. https:\/\/doi.org\/10.1186\/1749-8090-8-64","journal-title":"J Cardiothoracic Surg"},{"key":"1850_CR132","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.neuropharm.2014.01.011","volume":"79","author":"J Lai","year":"2014","unstructured":"Lai J, Hu M, Wang H, Hu M, Long Y, Miao M, Li J, Wang X, Kong L, Hong H (2014a) Montelukast targeting the cysteinyl leukotriene receptor 1 ameliorates A\u03b21-42-induced memory impairment and neuroinflammatory and apoptotic responses in mice. Neuropharmacology 79:707\u2013714. https:\/\/doi.org\/10.1016\/j.neuropharm.2014.01.011","journal-title":"Neuropharmacology"},{"key":"1850_CR133","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.neuint.2014.05.006","volume":"75","author":"J Lai","year":"2014","unstructured":"Lai J, Mei ZL, Wang H, Hu M, Long Y, Miao MX, Li N, Hong H (2014b) Montelukast rescues primary neurons against A\u03b21\u201342-induced toxicity through inhibiting CysLT1R-mediated NF-\u03baB signaling. Neurochem Int 75:26\u201331. https:\/\/doi.org\/10.1016\/j.neuint.2014.05.006","journal-title":"Neurochem Int"},{"issue":"5","key":"1850_CR134","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1001\/archopht.121.5.615","volume":"121","author":"A Lambiase","year":"2003","unstructured":"Lambiase A (2003) Montelukast, a leukotriene receptor antagonist, in vernal keratoconjunctivitis associated with asthma. Arch Ophthalmol 121(5):615. https:\/\/doi.org\/10.1001\/archopht.121.5.615","journal-title":"Arch Ophthalmol"},{"key":"1850_CR135","doi-asserted-by":"publisher","DOI":"10.2147\/PGPM.S30626","author":"J Lang","year":"2013","unstructured":"Lang J, Blake K (2013) Role of biomarkers in understanding and treating children with asthma: towards personalized care. Pharmacogenomics Personalized Med. https:\/\/doi.org\/10.2147\/PGPM.S30626","journal-title":"Pharmacogenomics Personalized Med"},{"key":"1850_CR136","first-page":"203","volume":"22","author":"JC Lee","year":"2018","unstructured":"Lee JC (2018) Therapeutic effect of montelukast in hepatic ischemia-reperfusion injury in rats. Euro J Anatomy 22:203\u2013212","journal-title":"Euro J Anatomy"},{"issue":"10","key":"1850_CR137","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3345\/cep.2019.00325","volume":"63","author":"YJ Lee","year":"2020","unstructured":"Lee YJ, Kim C-K (2020) Montelukast use over the past 20 years: monitoring of its effects and safety issues. Clin Exp Pediatrics 63(10):376\u2013381. https:\/\/doi.org\/10.3345\/cep.2019.00325","journal-title":"Clin Exp Pediatrics"},{"issue":"1","key":"1850_CR138","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4168\/aair.2011.3.1.3","volume":"3","author":"RU Lee","year":"2011","unstructured":"Lee RU, Stevenson DD (2011) Aspirin-exacerbated respiratory disease: evaluation and management. Allergy, Asthma Immunol Res 3(1):3. https:\/\/doi.org\/10.4168\/aair.2011.3.1.3","journal-title":"Allergy, Asthma Immunol Res"},{"issue":"4","key":"1850_CR139","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s00408-015-9743-5","volume":"193","author":"JH Lee","year":"2015","unstructured":"Lee JH, Kim HJ, Kim YH (2015) The effectiveness of anti-leukotriene agents in patients with COPD: a systemic review and meta-analysis. Lung 193(4):477\u2013486. https:\/\/doi.org\/10.1007\/s00408-015-9743-5","journal-title":"Lung"},{"key":"1850_CR140","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.neuroscience.2014.07.058","volume":"277","author":"QF Lenz","year":"2014","unstructured":"Lenz QF, Arroyo DS, Temp FR, Poersch AB, Masson CJ, Jesse AC, Marafiga JR, Reschke CR, Iribarren P, Mello CF (2014) Cysteinyl leukotriene receptor (CysLT) antagonists decrease pentylenetetrazol-induced seizures and blood\u2013brain barrier dysfunction. Neuroscience 277:859\u2013871. https:\/\/doi.org\/10.1016\/j.neuroscience.2014.07.058","journal-title":"Neuroscience"},{"issue":"3","key":"1850_CR141","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3390\/medsci7030045","volume":"7","author":"KL Li","year":"2019","unstructured":"Li KL, Lee AY, Abuzeid WM (2019) Aspirin exacerbated respiratory disease: epidemiology, pathophysiology, and management. Med Sci 7(3):45. https:\/\/doi.org\/10.3390\/medsci7030045","journal-title":"Med Sci"},{"key":"1850_CR142","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.2147\/DDDT.S298355","volume":"15","author":"W Li","year":"2021","unstructured":"Li W, Wang Y, Pei Y, Xia Y (2021a) Pharmacokinetics and bioequivalence evaluation of two montelukast sodium chewable tablets in healthy Chinese volunteers under fasted and fed conditions. Drug Design, Develop Ther 15:1091\u20131099. https:\/\/doi.org\/10.2147\/DDDT.S298355","journal-title":"Drug Design, Develop Ther"},{"issue":"1","key":"1850_CR143","doi-asserted-by":"publisher","first-page":"8476","DOI":"10.1080\/21655979.2021.1984003","volume":"12","author":"Z Li","year":"2021","unstructured":"Li Z, Wang J, Ma Y (2021b) Montelukast attenuates interleukin IL-1\u03b2-induced oxidative stress and apoptosis in chondrocytes by inhibiting CYSLTR1 (Cysteinyl Leukotriene Receptor 1) and activating KLF2 (Kruppel Like Factor 2). Bioengineered 12(1):8476\u20138484. https:\/\/doi.org\/10.1080\/21655979.2021.1984003","journal-title":"Bioengineered"},{"issue":"2","key":"1850_CR144","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3390\/molecules25020349","volume":"25","author":"I Liakh","year":"2020","unstructured":"Liakh I, Pakiet A, Sledzinski T, Mika A (2020) Methods of the analysis of oxylipins in biological samples. Molecules 25(2):349. https:\/\/doi.org\/10.3390\/molecules25020349","journal-title":"Molecules"},{"issue":"6","key":"1850_CR145","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s10557-009-6211-6","volume":"23","author":"D Liu","year":"2009","unstructured":"Liu D, Ge S, Zhou G, Xu G, Zhang R, Zhu W, Liu Z, Cheng S, Liu X (2009) Montelukast inhibits matrix metalloproteinases expression in atherosclerotic rabbits. Cardiovasc Drugs Ther 23(6):431\u2013437. https:\/\/doi.org\/10.1007\/s10557-009-6211-6","journal-title":"Cardiovasc Drugs Ther"},{"issue":"2","key":"1850_CR146","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1586\/ecp.13.2","volume":"6","author":"S Louie","year":"2013","unstructured":"Louie S, Zeki AA, Schivo M, Chan AL, Yoneda KY, Avdalovic M, Morrissey BM, Albertson TE (2013) The asthma\u2013chronic obstructive pulmonary disease overlap syndrome: pharmacotherapeutic considerations. Expert Rev Clin Pharmacol 6(2):197\u2013219. https:\/\/doi.org\/10.1586\/ecp.13.2","journal-title":"Expert Rev Clin Pharmacol"},{"key":"1850_CR147","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aax2518","author":"A Luginina","year":"2019","unstructured":"Luginina A, Gusach A, Marin E, Mishin A, Brouillette R, Popov P, Shiriaeva A, Besserer-Offroy \u00c9, Longpr\u00e9 J-M, Lyapina E, Ishchenko A, Patel N, Polovinkin V, Safronova N, Bogorodskiy A, Edelweiss E, Hu H, Weierstall U, Liu W, Cherezov V (2019) Structure-based mechanism of cysteinyl leukotriene receptor inhibition by antiasthmatic drugs. Sci Adv. https:\/\/doi.org\/10.1126\/sciadv.aax2518","journal-title":"Sci Adv"},{"issue":"10","key":"1850_CR148","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2023.105247","volume":"299","author":"A Luginina","year":"2023","unstructured":"Luginina A, Gusach A, Lyapina E, Khorn P, Safronova N, Shevtsov M, Dmitirieva D, Dashevskii D, Kotova T, Smirnova E, Borshchevskiy V, Cherezov V, Mishin A (2023) Structural diversity of leukotriene G-protein coupled receptors. J Biol Chem 299(10):105247. https:\/\/doi.org\/10.1016\/j.jbc.2023.105247","journal-title":"J Biol Chem"},{"issue":"3","key":"1850_CR149","doi-asserted-by":"publisher","first-page":"281","DOI":"10.4103\/0970-2113.180805","volume":"33","author":"R Magazine","year":"2016","unstructured":"Magazine R, Shahul H, Chogtu B, Kamath A (2016) Comparison of oral montelukast with oral zileuton in acute asthma: a randomized, double-blind, placebo-controlled study. Lung India 33(3):281. https:\/\/doi.org\/10.4103\/0970-2113.180805","journal-title":"Lung India"},{"issue":"12","key":"1850_CR150","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.3390\/ph16121658","volume":"16","author":"S Magramane","year":"2023","unstructured":"Magramane S, Vlahovi\u0107 K, Gordon P, K\u00e1llai-Szab\u00f3 N, Zelk\u00f3 R, Antal I, Farkas D (2023) Inhalation dosage forms: a focus on dry powder inhalers and their advancements. Pharmaceuticals 16(12):1658. https:\/\/doi.org\/10.3390\/ph16121658","journal-title":"Pharmaceuticals"},{"issue":"6","key":"1850_CR151","doi-asserted-by":"publisher","first-page":"748","DOI":"10.3109\/17453674.2010.533931","volume":"81","author":"MB Manigrasso","year":"2010","unstructured":"Manigrasso MB, O\u2019Connor JP (2010) Accelerated fracture healing in mice lacking the 5-lipoxygenase gene. Acta Orthop 81(6):748\u2013755. https:\/\/doi.org\/10.3109\/17453674.2010.533931","journal-title":"Acta Orthop"},{"key":"1850_CR152","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.taap.2018.09.012","volume":"358","author":"RM Mansour","year":"2018","unstructured":"Mansour RM, Ahmed MAE, El-Sahar AE, El Sayed NS (2018) Montelukast attenuates rotenone-induced microglial activation\/p38 MAPK expression in rats: possible role of its antioxidant, anti-inflammatory and antiapoptotic effects. Toxicol Appl Pharmacol 358:76\u201385. https:\/\/doi.org\/10.1016\/j.taap.2018.09.012","journal-title":"Toxicol Appl Pharmacol"},{"key":"1850_CR153","doi-asserted-by":"publisher","DOI":"10.20944\/preprints202207.0379.v1","author":"CF Marques","year":"2022","unstructured":"Marques CF, Marques MM, Justino GC (2022) Leukotrienes vs. montelukast\u2014activity, metabolism, and toxicity hints for repurposing. Pharmaceuticals. https:\/\/doi.org\/10.20944\/preprints202207.0379.v1","journal-title":"Pharmaceuticals"},{"issue":"3","key":"1850_CR154","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1007\/s13311-020-00836-3","volume":"17","author":"J Marschallinger","year":"2020","unstructured":"Marschallinger J, Altendorfer B, Rockenstein E, Holztrattner M, Garnweidner-Raith J, Pillichshammer N, Leister I, Hutter-Paier B, Strempfl K, Unger MS, Chishty M, Felder T, Johnson M, Attems J, Masliah E, Aigner L (2020) The leukotriene receptor antagonist montelukast reduces alpha-synuclein load and restores memory in an animal model of dementia with lewy bodies. Neurotherapeutics 17(3):1061\u20131074. https:\/\/doi.org\/10.1007\/s13311-020-00836-3","journal-title":"Neurotherapeutics"},{"key":"1850_CR155","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.redox.2015.08.006","volume":"6","author":"R Mashima","year":"2015","unstructured":"Mashima R, Okuyama T (2015) The role of lipoxygenases in pathophysiology; new insights and future perspectives. Redox Biol 6:297\u2013310. https:\/\/doi.org\/10.1016\/j.redox.2015.08.006","journal-title":"Redox Biol"},{"key":"1850_CR156","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000003870","author":"W Matsumiya","year":"2023","unstructured":"Matsumiya W, Karaca I, Pham BH, Akhavanrezayat A, Uludag G, Yasar C, Ghoraba H, Mobasserian A, Regenold J, Halim MS, Sepah YJ, Do DV, Chong V, Nguyen QD (2023) Association of oral montelukast with reduced odds of developing exudative age-related macular degeneration. Retina. https:\/\/doi.org\/10.1097\/IAE.0000000000003870","journal-title":"Retina"},{"issue":"2","key":"1850_CR157","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.drudis.2018.09.008","volume":"24","author":"J Michael","year":"2019","unstructured":"Michael J, Marschallinger J, Aigner L (2019) The leukotriene signaling pathway: a druggable target in Alzheimer\u2019s disease. Drug Discovery Today 24(2):505\u2013516. https:\/\/doi.org\/10.1016\/j.drudis.2018.09.008","journal-title":"Drug Discovery Today"},{"issue":"1","key":"1850_CR158","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/pharmaceutics13010012","volume":"13","author":"J Michael","year":"2020","unstructured":"Michael J, Bessa de Sousa D, Conway J, Gonzalez-Labrada E, Obeid R, Tevini J, Felder T, Hutter-Paier B, Zerbe H, Paiement N, Aigner L (2020) Improved bioavailability of montelukast through a novel oral mucoadhesive film in humans and mice. Pharmaceutics 13(1):12. https:\/\/doi.org\/10.3390\/pharmaceutics13010012","journal-title":"Pharmaceutics"},{"issue":"5","key":"1850_CR159","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.3390\/ijms22052782","volume":"22","author":"J Michael","year":"2021","unstructured":"Michael J, Zirknitzer J, Unger MS, Poupardin R, Rie\u00df T, Paiement N, Zerbe H, Hutter-Paier B, Reitsamer H, Aigner L (2021) The leukotriene receptor antagonist montelukast attenuates neuroinflammation and affects cognition in transgenic 5xFAD mice. Int J Mole Sci 22(5):2782. https:\/\/doi.org\/10.3390\/ijms22052782","journal-title":"Int J Mole Sci"},{"issue":"3","key":"1850_CR160","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.pathophys.2011.02.003","volume":"18","author":"AM Mohamadin","year":"2011","unstructured":"Mohamadin AM, Elberry AA, Elkablawy MA, Gawad HSA, Al-Abbasi FA (2011) Montelukast, a leukotriene receptor antagonist abrogates lipopolysaccharide-induced toxicity and oxidative stress in rat liver. Pathophysiology 18(3):235\u2013242. https:\/\/doi.org\/10.1016\/j.pathophys.2011.02.003","journal-title":"Pathophysiology"},{"issue":"1","key":"1850_CR161","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.pathophys.2015.01.001","volume":"22","author":"AM Mohamadin","year":"2015","unstructured":"Mohamadin AM, Elberry AA, Elkablawy MA, Gawad HSA, Al-Abbasi FA (2015) Corrigendum to \u201cMontelukast, a leukotriene receptor antagonist abrogates lipopolysaccharide-induced toxicity and oxidative stress in rat liver.\u201d Pathophysiology 22(1):85. https:\/\/doi.org\/10.1016\/j.pathophys.2015.01.001","journal-title":"Pathophysiology"},{"key":"1850_CR162","doi-asserted-by":"publisher","DOI":"10.1016\/j.prostaglandins.2020.106447","volume":"149","author":"MZ Mohamed","year":"2020","unstructured":"Mohamed MZ, Zenhom NM (2020) Mechanisms underlying the protective effect of leukotriene receptor antagonist montelukast against doxorubicin induced testicular injury in rats. Prostaglandins Other Lipid Mediators 149:106447. https:\/\/doi.org\/10.1016\/j.prostaglandins.2020.106447","journal-title":"Prostaglandins Other Lipid Mediators"},{"issue":"6","key":"1850_CR163","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.3390\/ph3061792","volume":"3","author":"P Montuschi","year":"2010","unstructured":"Montuschi P (2010) Role of leukotrienes and leukotriene modifiers in asthma. Pharmaceuticals 3(6):1792\u20131811. https:\/\/doi.org\/10.3390\/ph3061792","journal-title":"Pharmaceuticals"},{"issue":"1","key":"1850_CR164","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12301-020-00044-7","volume":"26","author":"AM Mukendi","year":"2020","unstructured":"Mukendi AM, Kruger D, Haffejee M (2020) Characteristics and management of testicular torsion in patients admitted to the urology department at chris hani baragwanath academic hospital. Afr J Urol 26(1):34. https:\/\/doi.org\/10.1186\/s12301-020-00044-7","journal-title":"Afr J Urol"},{"issue":"1","key":"1850_CR165","doi-asserted-by":"publisher","first-page":"3371","DOI":"10.1038\/s41598-024-53936-x","volume":"14","author":"M Muluhie","year":"2024","unstructured":"Muluhie M, Castiglioni L, Rzemieniec J, Mercuriali B, Gelosa P, Sironi L (2024) Montelukast, an available and safe anti-asthmatic drug, prevents maladaptive remodelling and maintains cardiac functionality following myocardial infarction. Sci Rep 14(1):3371. https:\/\/doi.org\/10.1038\/s41598-024-53936-x","journal-title":"Sci Rep"},{"issue":"19\u201320","key":"1850_CR166","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.lfs.2012.03.010","volume":"90","author":"A Muthuraman","year":"2012","unstructured":"Muthuraman A, Ramesh M, Sood S (2012) Ameliorative potential of montelukast on ischemia\u2013reperfusion injury induced vasculitic neuropathic pain in rat. Life Sci 90(19\u201320):755\u2013762. https:\/\/doi.org\/10.1016\/j.lfs.2012.03.010","journal-title":"Life Sci"},{"key":"1850_CR167","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.neulet.2018.05.052","volume":"682","author":"VB Nagarajan","year":"2018","unstructured":"Nagarajan VB, Marathe PA (2018) Effect of montelukast in experimental model of Parkinson\u2019s disease. Neurosci Lett 682:100\u2013105. https:\/\/doi.org\/10.1016\/j.neulet.2018.05.052","journal-title":"Neurosci Lett"},{"issue":"6","key":"1850_CR168","doi-asserted-by":"publisher","first-page":"887","DOI":"10.2165\/00003495-200767060-00005","volume":"67","author":"A Nayak","year":"2007","unstructured":"Nayak A, Langdon RB (2007) Montelukast in the treatment of allergic rhinitis. Drugs 67(6):887\u2013901. https:\/\/doi.org\/10.2165\/00003495-200767060-00005","journal-title":"Drugs"},{"issue":"7","key":"1850_CR169","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0041786","volume":"7","author":"E Nobili","year":"2012","unstructured":"Nobili E, Salvado MD, Folkersen L, Castiglioni L, Kastrup J, Wetterholm A, Tremoli E, Hansson GK, Sironi L, Haeggstr\u00f6m JZ, Gabrielsen A (2012) Cysteinyl leukotriene signaling aggravates myocardial hypoxia in experimental atherosclerotic heart disease. PLoS ONE 7(7):e41786. https:\/\/doi.org\/10.1371\/journal.pone.0041786","journal-title":"PLoS ONE"},{"issue":"3","key":"1850_CR170","doi-asserted-by":"publisher","first-page":"403","DOI":"10.3109\/0886022X.2012.761040","volume":"35","author":"A Otunctemur","year":"2013","unstructured":"Otunctemur A, Ozbek E, Cekmen M, Cakir SS, Dursun M, Polat EC, Somay A, Ozbay N (2013) Protective effect of montelukast which is cysteinyl-leukotriene receptor antagonist on gentamicin-induced nephrotoxicity and oxidative damage in rat kidney. Ren Fail 35(3):403\u2013410. https:\/\/doi.org\/10.3109\/0886022X.2012.761040","journal-title":"Ren Fail"},{"issue":"2","key":"1850_CR171","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1590\/S1677-5538.IBJU.2015.02.14","volume":"41","author":"A Otunctemur","year":"2015","unstructured":"Otunctemur A, Ozbek E, Cakir SS, Dursun M, Cekmen M, Polat EC, Ozcan L, Somay A, Ozbay N (2015) Beneficial effects montelukast, cysteinyl-leukotriene receptor antagonist, on renal damage after unilateral ureteral obstruction in rats. Int Braz J Urol 41(2):279\u2013287. https:\/\/doi.org\/10.1590\/S1677-5538.IBJU.2015.02.14","journal-title":"Int Braz J Urol"},{"issue":"1","key":"1850_CR172","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.jss.2008.08.006","volume":"159","author":"E \u00d6zkan","year":"2010","unstructured":"\u00d6zkan E, Yardimci S, Dulundu E, Topalo\u011flu \u00dc, \u015eehirli \u00d6, Ercan F, Velio\u011flu-\u00d6\u011f\u00fcn\u00e7 A, \u015eener G (2010) Protective potential of montelukast against hepatic ischemia\/reperfusion injury in rats. J Surg Res 159(1):588\u2013594. https:\/\/doi.org\/10.1016\/j.jss.2008.08.006","journal-title":"J Surg Res"},{"issue":"3","key":"1850_CR173","doi-asserted-by":"publisher","first-page":"174","DOI":"10.5489\/cuaj.09072","volume":"4","author":"H Ozturk","year":"2010","unstructured":"Ozturk H, Ozturk H, Gideroglu K, Terzi H, Bugdayci G (2010) Montelukast protects against testes ischemia\/reperfusion injury in rats. Canadian Urol Assoc J 4(3):174\u2013179. https:\/\/doi.org\/10.5489\/cuaj.09072","journal-title":"Canadian Urol Assoc J"},{"issue":"1","key":"1850_CR174","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1177\/2040622310383343","volume":"2","author":"P Paggiaro","year":"2011","unstructured":"Paggiaro P, Bacci E (2011) Montelukast in asthma: a review of its efficacy and place in therapy. Ther Adv Chronic Dis 2(1):47\u201358. https:\/\/doi.org\/10.1177\/2040622310383343","journal-title":"Ther Adv Chronic Dis"},{"issue":"5","key":"1850_CR175","doi-asserted-by":"publisher","first-page":"110","DOI":"10.4103\/0975-7406.94160","volume":"4","author":"R Panchal","year":"2012","unstructured":"Panchal R, Patel H, Patel V, Joshi P, Parikh A (2012) Formulation and evalution of montelukast sodium\u2014chitosan based spray dried microspheres for pulmonary drug delivery. J Pharm Bioallied Sci 4(5):110. https:\/\/doi.org\/10.4103\/0975-7406.94160","journal-title":"J Pharm Bioallied Sci"},{"issue":"4","key":"1850_CR176","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.xphs.2016.12.025","volume":"106","author":"B Patel","year":"2017","unstructured":"Patel B, Rashid J, Gupta N, Ahsan F (2017) Low-Molecular-weight heparin-coated and montelukast-filled inhalable particles: a dual-drug delivery system for combination therapy in asthma. J Pharm Sci 106(4):1124\u20131135. https:\/\/doi.org\/10.1016\/j.xphs.2016.12.025","journal-title":"J Pharm Sci"},{"issue":"1","key":"1850_CR177","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.ejpb.2014.05.019","volume":"88","author":"A Patil-Gadhe","year":"2014","unstructured":"Patil-Gadhe A, Pokharkar V (2014) Montelukast-loaded nanostructured lipid carriers: Part I Oral bioavailability improvement. Euro J Pharm Biopharm 88(1):160\u2013168. https:\/\/doi.org\/10.1016\/j.ejpb.2014.05.019","journal-title":"Euro J Pharm Biopharm"},{"issue":"1","key":"1850_CR178","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.ejpb.2014.07.007","volume":"88","author":"A Patil-Gadhe","year":"2014","unstructured":"Patil-Gadhe A, Kyadarkunte A, Patole M, Pokharkar V (2014) Montelukast-loaded nanostructured lipid carriers: Part II Pulmonary drug delivery and in vitro\u2013in vivo aerosol performance. Euro J Pharm Biopharm 88(1):169\u2013177. https:\/\/doi.org\/10.1016\/j.ejpb.2014.07.007","journal-title":"Euro J Pharm Biopharm"},{"issue":"1","key":"1850_CR179","doi-asserted-by":"publisher","first-page":"109","DOI":"10.4155\/tde.10.16","volume":"1","author":"KS Paudel","year":"2010","unstructured":"Paudel KS, Milewski M, Swadley CL, Brogden NK, Ghosh P, Stinchcomb AL (2010) Challenges and opportunities in dermal\/transdermal delivery. Ther Delivery 1(1):109\u2013131. https:\/\/doi.org\/10.4155\/tde.10.16","journal-title":"Ther Delivery"},{"issue":"2","key":"1850_CR180","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1093\/cvr\/cvq016","volume":"86","author":"D Poeckel","year":"2010","unstructured":"Poeckel D, Funk CD (2010) The 5-lipoxygenase\/leukotriene pathway in preclinical models of cardiovascular disease. Cardiovasc Res 86(2):243\u2013253. https:\/\/doi.org\/10.1093\/cvr\/cvq016","journal-title":"Cardiovasc Res"},{"issue":"1","key":"1850_CR181","first-page":"15","volume":"52","author":"L Ponce","year":"2011","unstructured":"Ponce L, Arjona M, Blanco G, Alvarez S, Arcila E, Ortega A, Nu\u00f1ez D, Verzura J, Tovar R, Bethencourt S, Riera R, Mora-Orta S, Corado J (2011) The effect of montelukast in a model of gouty arthritis induced by sodium monourate crystals. Invest Clin 52(1):15\u201322","journal-title":"Invest Clin"},{"issue":"6","key":"1850_CR182","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1111\/j.1398-9995.2006.01007.x","volume":"61","author":"DB Price","year":"2006","unstructured":"Price DB, Swern A, Tozzi CA, Philip G, Polos P (2006) Effect of montelukast on lung function in asthma patients with allergic rhinitis: analysis from the COMPACT trial. Allergy 61(6):737\u2013742. https:\/\/doi.org\/10.1111\/j.1398-9995.2006.01007.x","journal-title":"Allergy"},{"key":"1850_CR183","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.01070","author":"S Pu","year":"2019","unstructured":"Pu S, Liu Q, Li Y, Li R, Wu T, Zhang Z, Huang C, Yang X, He J (2019) Montelukast prevents mice against acetaminophen-induced liver injury. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2019.01070","journal-title":"Front Pharmacol"},{"issue":"2","key":"1850_CR184","doi-asserted-by":"publisher","first-page":"1","DOI":"10.56782\/pps.38","volume":"20","author":"B Pyrak","year":"2022","unstructured":"Pyrak B, Rogacka K, Pisklak DM (2022) Anti-leukotriene drugs in the therapy of inflammatory diseases. Prospects Pharm Sci 20(2):1\u201323. https:\/\/doi.org\/10.56782\/pps.38","journal-title":"Prospects Pharm Sci"},{"issue":"1","key":"1850_CR185","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.1038\/s41467-022-30050-y","volume":"13","author":"J Radke","year":"2022","unstructured":"Radke J, Ishaque N, Koll R, Gu Z, Schumann E, Sieverling L, Uhrig S, H\u00fcbschmann D, Toprak UH, L\u00f3pez C, Hostench XP, Borgoni S, Juraeva D, Pritsch F, Paramasivam N, Balasubramanian GP, Schlesner M, Sahay S, Weniger M, Heppner FL (2022) The genomic and transcriptional landscape of primary central nervous system lymphoma. Nature Commun 13(1):2558. https:\/\/doi.org\/10.1038\/s41467-022-30050-y","journal-title":"Nature Commun"},{"issue":"11","key":"1850_CR186","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.3390\/biomedicines10112845","volume":"10","author":"M Reina-Couto","year":"2022","unstructured":"Reina-Couto M, Santos-Oliveira M, Pereira-Terra P, Silva-Pereira C, Quelhas-Santos J, Duarte \u00c1, Martins S, Serr\u00e3o P, Dias CC, Morato M, Guimar\u00e3es JT, Roncon-Albuquerque R, Paiva J-A, Albino-Teixeira A, Sousa T (2022) Urinary cysteinyl leukotrienes as biomarkers of endothelial activation, inflammation and oxidative stress and their relationship with organ dysfunction in human septic shock. Biomedicines 10(11):2845. https:\/\/doi.org\/10.3390\/biomedicines10112845","journal-title":"Biomedicines"},{"issue":"3","key":"1850_CR187","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s00011-022-01682-z","volume":"72","author":"M Reina-Couto","year":"2023","unstructured":"Reina-Couto M, Roboredo-Madeira M, Pereira-Terra P, Silva-Pereira C, Martins S, Teixeira-Santos L, Pinho D, Dias A, Cordeiro G, Dias CC, Sarmento A, Tavares M, Guimar\u00e3es JT, Roncon-Albuquerque R, Paiva J-A, Albino-Teixeira A, Sousa T (2023) Evaluation of urinary cysteinyl leukotrienes as biomarkers of severity and putative therapeutic targets in COVID-19 patients. Inflammation Res 72(3):475\u2013491. https:\/\/doi.org\/10.1007\/s00011-022-01682-z","journal-title":"Inflammation Res"},{"issue":"11","key":"1850_CR188","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1001\/archinte.158.11.1213","volume":"158","author":"TF Reiss","year":"1998","unstructured":"Reiss TF (1998) Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma. A multicenter randomized, double-blind trial. Arch Int Med 158(11):1213. https:\/\/doi.org\/10.1001\/archinte.158.11.1213","journal-title":"Arch Int Med"},{"issue":"18","key":"1850_CR189","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.2174\/092986707781368522","volume":"14","author":"G Riccioni","year":"2007","unstructured":"Riccioni G, Bucciarelli T, Mancini B, Di Ilio C, D\u2019Orazio N (2007) Antileukotriene drugs: clinical application, effectiveness and safety. Curr Med Chem 14(18):1966\u20131977. https:\/\/doi.org\/10.2174\/092986707781368522","journal-title":"Curr Med Chem"},{"issue":"10","key":"1850_CR190","first-page":"1739","volume":"74","author":"E Ringdahl","year":"2006","unstructured":"Ringdahl E, Teague L (2006) Testicular torsion. Am Family Phys 74(10):1739\u20131743","journal-title":"Am Family Phys"},{"key":"1850_CR191","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/696383","volume":"2014","author":"SWS Rocha","year":"2014","unstructured":"Rocha SWS, de Fran\u00e7a MER, Rodrigues GB, Barbosa KPS, Nunes AKS, Pastor AF, Oliveira AGV, Oliveira WH, Luna RLA, Peixoto CA (2014) Diethylcarbamazine reduces chronic inflammation and fibrosis in carbon tetrachloride- (CCl 4 -) induced liver injury in mice. Mediators Inflammation 2014:1\u201315. https:\/\/doi.org\/10.1155\/2014\/696383","journal-title":"Mediators Inflammation"},{"key":"1850_CR192","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.rmed.2018.01.002","volume":"135","author":"JC Rodr\u00edguez-Jim\u00e9nez","year":"2018","unstructured":"Rodr\u00edguez-Jim\u00e9nez JC, Moreno-Paz FJ, Ter\u00e1n LM, Guan\u00ed-Guerra E (2018) Aspirin exacerbated respiratory disease: Current topics and trends. Respiratory Med 135:62\u201375. https:\/\/doi.org\/10.1016\/j.rmed.2018.01.002","journal-title":"Respiratory Med"},{"issue":"1","key":"1850_CR193","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/S1665-2681(19)31950-7","volume":"6","author":"A Rodr\u00edguez-Vilarrupla","year":"2007","unstructured":"Rodr\u00edguez-Vilarrupla A, Fern\u00e1ndez M, Bosch J, Carles Garc\u00eda-Pag\u00e1n J (2007) Current concepts on the pathophysiology of portal hypertension. Ann Hepatol 6(1):28\u201336. https:\/\/doi.org\/10.1016\/S1665-2681(19)31950-7","journal-title":"Ann Hepatol"},{"key":"1850_CR194","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1100\/tsw.2007.34","volume":"7","author":"A Rossi","year":"2007","unstructured":"Rossi A, Pergola C, Cuzzocrea S, Sautebin L (2007) The role of 5-lipoxygenase and leukotrienes in shock and ischemia-reperfusion injury. Sci World J 7:56\u201374. https:\/\/doi.org\/10.1100\/tsw.2007.34","journal-title":"Sci World J"},{"issue":"12","key":"1850_CR195","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1248\/bpb.32.2002","volume":"32","author":"U Roy","year":"2009","unstructured":"Roy U, Chakravarty G, Honer ZBK, Mondal D (2009) Montelukast is a potent and durable inhibitor of multidrug resistance protein 2-mediated efflux of taxol and saquinavir. Biol Pharm Bullet 32(12):2002\u20132009. https:\/\/doi.org\/10.1248\/bpb.32.2002","journal-title":"Biol Pharm Bullet"},{"issue":"1","key":"1850_CR196","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1097\/MNH.0000000000000381","volume":"27","author":"M Rubinstein","year":"2018","unstructured":"Rubinstein M, Dvash E (2018) Leukotrienes and kidney diseases. Curr Opinion Nephrol Hypertension 27(1):42\u201348. https:\/\/doi.org\/10.1097\/MNH.0000000000000381","journal-title":"Curr Opinion Nephrol Hypertension"},{"issue":"71","key":"1850_CR197","first-page":"S29","volume":"2013","author":"EM Ruderman","year":"2013","unstructured":"Ruderman EM (2013) The role of concomitant methotrexate in biologic therapy for rheumatoid arthritis. Bullet Hospital Joint Dis 2013(71):S29-32","journal-title":"Bullet Hospital Joint Dis"},{"issue":"1","key":"1850_CR198","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s11064-014-1478-9","volume":"40","author":"MA Saad","year":"2015","unstructured":"Saad MA, Abdelsalam RM, Kenawy SA, Attia AS (2015) Montelukast, a cysteinyl leukotriene receptor-1 antagonist protects against hippocampal injury induced by transient global cerebral ischemia and reperfusion in rats. Neurochem Res 40(1):139\u2013150. https:\/\/doi.org\/10.1007\/s11064-014-1478-9","journal-title":"Neurochem Res"},{"key":"1850_CR199","first-page":"2415","volume":"10","author":"H Saheb","year":"2018","unstructured":"Saheb H, Sultan A, Sahib H (2018) Protective effect of montelukast against acute kidney injury in rats induced by diclofenac. J Pharm Sci Res 10:2415","journal-title":"J Pharm Sci Res"},{"key":"1850_CR200","first-page":"350","volume":"38","author":"S Satoh","year":"2003","unstructured":"Satoh S, Uetake S, Ohata M, Nakajima H, Yamauchi M (2003) Effect of type of dietary fat and ethanol on hepatic leukotriene level in experimental alcoholic liver disease. Nihon Aruk\u014dru Yakubutsu Igakkai Zasshi Japanese = J Alcohol Stud Drug Dependence 38:350\u2013363","journal-title":"Nihon Aruk\u014dru Yakubutsu Igakkai Zasshi Japanese = J Alcohol Stud Drug Dependence"},{"issue":"4","key":"1850_CR201","doi-asserted-by":"publisher","first-page":"968","DOI":"10.3748\/wjg.v20.i4.968","volume":"20","author":"S Savari","year":"2014","unstructured":"Savari S (2014) Cysteinyl leukotrienes and their receptors: bridging inflammation and colorectal cancer. World J Gastroenterol 20(4):968. https:\/\/doi.org\/10.3748\/wjg.v20.i4.968","journal-title":"World J Gastroenterol"},{"issue":"6","key":"1850_CR202","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.plefa.2005.07.008","volume":"73","author":"G \u015eener","year":"2005","unstructured":"\u015eener G, \u015eehirli \u00d6, \u00c7etinel \u015e, Ercan F, Y\u00fcksel M, Gedik N, Ye\u011fen B\u00c7 (2005) Amelioration of sepsis-induced hepatic and ileal injury in rats by the leukotriene receptor blocker montelukast. Prostaglandins Leukot Essent Fatty Acids 73(6):453\u2013462. https:\/\/doi.org\/10.1016\/j.plefa.2005.07.008","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"4","key":"1850_CR203","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.prostaglandins.2007.01.013","volume":"83","author":"G \u015eener","year":"2007","unstructured":"\u015eener G, Sakarcan A, \u015eehirli \u00d6, Ek\u015fio\u011flu-Demiralp E, \u015eener E, Ercan F, Gedik N, Ye\u011fen B\u00c7 (2007) Chronic renal failure-induced multiple-organ injury in rats is alleviated by the selective CysLT1 receptor antagonist montelukast. Prostaglandins Other Lipid Mediators 83(4):257\u2013267. https:\/\/doi.org\/10.1016\/j.prostaglandins.2007.01.013","journal-title":"Prostaglandins Other Lipid Mediators"},{"issue":"1","key":"1850_CR204","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.phrs.2006.02.007","volume":"54","author":"G Sener","year":"2006","unstructured":"Sener G, Sehirli O, Veliogluogunc A, Cetinel S, Gedik N, Caner M, Sakarcan A, Yegen B (2006) Montelukast protects against renal ischemia\/reperfusion injury in rats. Pharmacol Res 54(1):65\u201371. https:\/\/doi.org\/10.1016\/j.phrs.2006.02.007","journal-title":"Pharmacol Res"},{"key":"1850_CR205","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202201936R","author":"R Shioda","year":"2023","unstructured":"Shioda R, Jo-Watanabe A, Okuno T, Saeki K, Nakayama M, Suzuki Y, Yokomizo T (2023) The leukotriene B 4\/BLT1-dependent neutrophil accumulation exacerbates immune complex-mediated glomerulonephritis. FASEB J. https:\/\/doi.org\/10.1096\/fj.202201936R","journal-title":"FASEB J"},{"issue":"1\u20133","key":"1850_CR206","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.ejphar.2006.07.046","volume":"548","author":"N Shiota","year":"2006","unstructured":"Shiota N, Shimoura K, Okunishi H (2006) Pathophysiological role of mast cells in collagen-induced arthritis: study with a cysteinyl leukotriene receptor antagonist, montelukast. Euro J Pharmacol 548(1\u20133):158\u2013166. https:\/\/doi.org\/10.1016\/j.ejphar.2006.07.046","journal-title":"Euro J Pharmacol"},{"issue":"1","key":"1850_CR207","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.21871","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A (2025) Cancer statistics, 2025. CA: Cancer J Clin 75(1):10\u201345. https:\/\/doi.org\/10.3322\/caac.21871","journal-title":"CA: Cancer J Clin"},{"issue":"8","key":"1850_CR208","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1111\/all.15258","volume":"77","author":"M Sokolowska","year":"2022","unstructured":"Sokolowska M, Rovati GE, Diamant Z, Untersmayr E, Schwarze J, Lukasik Z, Sava F, Angelina A, Palomares O, Akdis CA, O\u2019Mahony L, Jesenak M, Pfaar O, Torres MJ, Sanak M, Dahl\u00e9n S, Woszczek G (2022) Effects of non-steroidal anti-inflammatory drugs and other eicosanoid pathway modifiers on antiviral and allergic responses: EAACI task force on eicosanoids consensus report in times of COVID-19. Allergy 77(8):2337\u20132354. https:\/\/doi.org\/10.1111\/all.15258","journal-title":"Allergy"},{"issue":"2","key":"1850_CR209","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s13311-018-0621-8","volume":"15","author":"T Sprenger","year":"2018","unstructured":"Sprenger T, Viana M, Tassorelli C (2018) Current prophylactic medications for migraine and their potential mechanisms of action. Neurotherapeutics 15(2):313\u2013323. https:\/\/doi.org\/10.1007\/s13311-018-0621-8","journal-title":"Neurotherapeutics"},{"issue":"4","key":"1850_CR210","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/S1081-1206(10)61156-8","volume":"95","author":"I Stelmach","year":"2005","unstructured":"Stelmach I, Korzeniewska A, Stelmach W, Majak P, Grzelewski T, Jerzynska J (2005) Effects of montelukast treatment on clinical and inflammatory variables in patients with cystic fibrosis. Ann Allergy, Asthma Immunol 95(4):372\u2013380. https:\/\/doi.org\/10.1016\/S1081-1206(10)61156-8","journal-title":"Ann Allergy, Asthma Immunol"},{"issue":"5","key":"1850_CR211","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1097\/TA.0000000000000231","volume":"76","author":"JR Stringham","year":"2014","unstructured":"Stringham JR, Moore EE, Gamboni F, Harr JN, Fragoso M, Chin TL, Carr CE, Silliman CC, Banerjee A (2014) Mesenteric lymph diversion abrogates 5-lipoxygenase activation in the kidney following trauma and hemorrhagic shock. Jo Trauma Acute Care Surg 76(5):1214\u20131221. https:\/\/doi.org\/10.1097\/TA.0000000000000231","journal-title":"Jo Trauma Acute Care Surg"},{"issue":"2","key":"1850_CR212","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/j.1472-8206.2011.00996.x","volume":"27","author":"GM Suddek","year":"2013","unstructured":"Suddek GM (2013) Montelukast ameliorates kidney function and urinary bladder sensitivity in experimentally induced renal dysfunction in rats. Fundamental Clin Pharmacol 27(2):186\u2013191. https:\/\/doi.org\/10.1111\/j.1472-8206.2011.00996.x","journal-title":"Fundamental Clin Pharmacol"},{"key":"1850_CR213","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.neuropharm.2012.08.026","volume":"65","author":"S-S Tang","year":"2013","unstructured":"Tang S-S, Wang X-Y, Hong H, Long Y, Li Y-Q, Xiang G-Q, Jiang L-Y, Zhang H-T, Liu L-P, Miao M-X, Hu M, Zhang T-T, Hu W, Ji H, Ye F-Y (2013) Leukotriene D4 induces cognitive impairment through enhancement of CysLT1R-mediated amyloid-\u03b2 generation in mice. Neuropharmacology 65:182\u2013192. https:\/\/doi.org\/10.1016\/j.neuropharm.2012.08.026","journal-title":"Neuropharmacology"},{"issue":"8","key":"1850_CR214","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1080\/15384047.2018.1451279","volume":"19","author":"C Tang","year":"2018","unstructured":"Tang C, Lei H, Zhang J, Liu M, Jin J, Luo H, Xu H, Wu Y (2018) Montelukast inhibits hypoxia inducible factor-1\u03b1 translation in prostate cancer cells. Cancer Biol Ther 19(8):715\u2013721. https:\/\/doi.org\/10.1080\/15384047.2018.1451279","journal-title":"Cancer Biol Ther"},{"issue":"S1","key":"1850_CR215","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s10195-017-0474-7","volume":"18","author":"U Tarantino","year":"2017","unstructured":"Tarantino U, Iolascon G, Cianferotti L, Masi L, Marcucci G, Giusti F, Marini F, Parri S, Feola M, Rao C, Piccirilli E, Zanetti EB, Cittadini N, Alvaro R, Moretti A, Calafiore D, Toro G, Gimigliano F, Resmini G, Brandi ML (2017) Clinical guidelines for the prevention and treatment of osteoporosis: summary statements and recommendations from the Italian society for orthopaedics and traumatology. J Orthopaedics Traumatol 18(S1):3\u201336. https:\/\/doi.org\/10.1007\/s10195-017-0474-7","journal-title":"J Orthopaedics Traumatol"},{"key":"1850_CR216","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.003448","author":"MC Tattersall","year":"2016","unstructured":"Tattersall MC, Barnet JH, Korcarz CE, Hagen EW, Peppard PE, Stein JH (2016) Late-onset asthma predicts cardiovascular disease events: the wisconsin sleep cohort. J Am Heart Assoc. https:\/\/doi.org\/10.1161\/JAHA.116.003448","journal-title":"J Am Heart Assoc"},{"key":"1850_CR217","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2147\/JEP.S277720","volume":"13","author":"BA Tesfaye","year":"2021","unstructured":"Tesfaye BA, Hailu HG, Zewdie KA, Ayza MA, Berhe DF (2021) Montelukast: the new therapeutic option for the treatment of epilepsy. J Exp Pharmacol 13:23\u201331. https:\/\/doi.org\/10.2147\/JEP.S277720","journal-title":"J Exp Pharmacol"},{"issue":"2\u20133","key":"1850_CR218","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s12026-014-8492-5","volume":"58","author":"W Tian","year":"2014","unstructured":"Tian W, Jiang X, Sung YK, Qian J, Yuan K, Nicolls MR (2014) Leukotrienes in pulmonary arterial hypertension. Immunol Res 58(2\u20133):387\u2013393. https:\/\/doi.org\/10.1007\/s12026-014-8492-5","journal-title":"Immunol Res"},{"key":"1850_CR219","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1187181","author":"VL Trivedi","year":"2023","unstructured":"Trivedi VL, Soni R, Dhyani P, Sati P, Tejada S, Sureda A, Setzer WN, Faizal ARA, Modu B, Butnariu M, Sharifi-Rad J (2023) Anti-cancer properties of boswellic acids: mechanism of action as anti-cancerous agent. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2023.1187181","journal-title":"Front Pharmacol"},{"issue":"7","key":"1850_CR220","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.3390\/ijms18071353","volume":"18","author":"M-J Tsai","year":"2017","unstructured":"Tsai M-J, Chang W-A, Tsai P-H, Wu C-Y, Ho Y-W, Yen M-C, Lin Y-S, Kuo P-L, Hsu Y-L (2017) Montelukast induces apoptosis-inducing factor-mediated cell death of lung cancer cells. Int J Mole Sci 18(7):1353. https:\/\/doi.org\/10.3390\/ijms18071353","journal-title":"Int J Mole Sci"},{"issue":"1","key":"1850_CR221","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3390\/ijms23010120","volume":"23","author":"M-J Tsai","year":"2021","unstructured":"Tsai M-J, Chang W-A, Chuang C-H, Wu K-L, Cheng C-H, Sheu C-C, Hsu Y-L, Hung J-Y (2021) Cysteinyl leukotriene pathway and cancer. Int J Mole Sci 23(1):120. https:\/\/doi.org\/10.3390\/ijms23010120","journal-title":"Int J Mole Sci"},{"issue":"1","key":"1850_CR222","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ejphar.2006.11.009","volume":"557","author":"H Tu\u011ftepe","year":"2007","unstructured":"Tu\u011ftepe H, \u015eener G, \u00c7etinel \u015e, Velio\u011flu-\u00d6\u011f\u00fcn\u00e7 A, Ye\u011fen B\u00c7 (2007) Oxidative renal damage in pyelonephritic rats is ameliorated by montelukast, a selective leukotriene CysLT1 receptor antagonist. Euro J Pharmacol 557(1):69\u201375. https:\/\/doi.org\/10.1016\/j.ejphar.2006.11.009","journal-title":"Euro J Pharmacol"},{"issue":"17","key":"1850_CR223","doi-asserted-by":"publisher","first-page":"3564","DOI":"10.3390\/polym14173564","volume":"14","author":"F Ullah","year":"2022","unstructured":"Ullah F, Shah KU, Shah SU, Nawaz A, Nawaz T, Khan KA, Alserihi RF, Tayeb HH, Tabrez S, Alfatama M (2022) Synthesis, characterization and in vitro evaluation of chitosan nanoparticles physically admixed with lactose microspheres for pulmonary delivery of montelukast. Polymers 14(17):3564. https:\/\/doi.org\/10.3390\/polym14173564","journal-title":"Polymers"},{"issue":"6","key":"1850_CR224","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s00345-004-0451-7","volume":"22","author":"A Unsal","year":"2004","unstructured":"Unsal A, Devrim E, Guven C, Eroglu M, Durak I, Bozoklu A, Balbay MD (2004) Propofol attenuates reperfusion injury after testicular torsion and detorsion. World J Urol 22(6):461\u2013465. https:\/\/doi.org\/10.1007\/s00345-004-0451-7","journal-title":"World J Urol"},{"issue":"5","key":"1850_CR225","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1177\/009127009903900509","volume":"39","author":"A Van Hecken","year":"1999","unstructured":"Van Hecken A, Depr\u00e9 M, Verbesselt R, Wynants K, De Lepeleire I, Arnout J, Wong PH, Freeman A, Holland S, Gertz B, De Schepper PJ (1999) Effect of montelukast on the pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers. J Clin Pharmacol 39(5):495\u2013500","journal-title":"J Clin Pharmacol"},{"issue":"11","key":"1850_CR226","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1016\/j.rmed.2006.02.026","volume":"100","author":"JC Virchow","year":"2006","unstructured":"Virchow JC, Bachert C (2006) Efficacy and safety of montelukast in adults with asthma and allergic rhinitis. Respiratory Med 100(11):1952\u20131959. https:\/\/doi.org\/10.1016\/j.rmed.2006.02.026","journal-title":"Respiratory Med"},{"issue":"4","key":"1850_CR227","doi-asserted-by":"publisher","first-page":"147","DOI":"10.5603\/AA.2022.0013","volume":"28","author":"A Wachsmann-Maga","year":"2022","unstructured":"Wachsmann-Maga A, Kaszuba M, Maga M, W\u0142odarczyk A, Kr\u0119\u017cel J, Kaczmarczyk P, Bogucka K, Maga P (2022) Leukotrienes in the atherosclerotic cardiovascular diseases\u2014a systematic review. Acta Angiologica 28(4):147\u2013153. https:\/\/doi.org\/10.5603\/AA.2022.0013","journal-title":"Acta Angiologica"},{"issue":"11","key":"1850_CR228","doi-asserted-by":"publisher","first-page":"5606","DOI":"10.3390\/ijms22115606","volume":"22","author":"J Wallin","year":"2021","unstructured":"Wallin J, Svenningsson P (2021) Potential effects of leukotriene receptor antagonist montelukast in treatment of neuroinflammation in parkinson\u2019s disease. Int J Mole Sci 22(11):5606. https:\/\/doi.org\/10.3390\/ijms22115606","journal-title":"Int J Mole Sci"},{"issue":"3","key":"1850_CR229","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1124\/dmd.104.002766","volume":"33","author":"RL Walsky","year":"2005","unstructured":"Walsky RL, Obach RS, Gaman EA, Gleeson J-PR, Proctor WR (2005) Selective inhibition of human cytochrome P4502C8 BY MONTELUKAST. Drug Metab Disposition 33(3):413\u2013418. https:\/\/doi.org\/10.1124\/dmd.104.002766","journal-title":"Drug Metab Disposition"},{"issue":"3","key":"1850_CR230","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nrc2809","volume":"10","author":"D Wang","year":"2010","unstructured":"Wang D, DuBois RN (2010) Eicosanoids and cancer. Nature Rev Cancer 10(3):181\u2013193. https:\/\/doi.org\/10.1038\/nrc2809","journal-title":"Nature Rev Cancer"},{"issue":"3","key":"1850_CR231","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.neuint.2013.01.002","volume":"62","author":"XY Wang","year":"2013","unstructured":"Wang XY, Tang SS, Hu M, Long Y, Li YQ, Liao MX, Ji H, Hong H (2013) Leukotriene D4 induces amyloid-\u03b2 generation via CysLT1R-mediated NF-\u03baB pathways in primary neurons. Neurochem Int 62(3):340\u2013347. https:\/\/doi.org\/10.1016\/j.neuint.2013.01.002","journal-title":"Neurochem Int"},{"key":"1850_CR232","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/9046842","volume":"2020","author":"H Wang","year":"2020","unstructured":"Wang H, Li N, Huang H (2020) Asthma in pregnancy: pathophysiology, diagnosis, whole-course management, and medication safety. Canadian Respiratory J 2020:1\u201310. https:\/\/doi.org\/10.1155\/2020\/9046842","journal-title":"Canadian Respiratory J"},{"key":"1850_CR233","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1287320","author":"H Wang","year":"2023","unstructured":"Wang H, Ji Q, Liao C, Tian L (2023) A systematic review and meta-analysis of loratadine combined with montelukast for the treatment of allergic rhinitis. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2023.1287320","journal-title":"Front Pharmacol"},{"issue":"9","key":"1850_CR234","doi-asserted-by":"publisher","first-page":"4346","DOI":"10.21037\/qims-22-281","volume":"12","author":"YXJ W\u00e1ng","year":"2022","unstructured":"W\u00e1ng YXJ, Xiao B-H (2022) Estimations of bone mineral density defined osteoporosis prevalence and cutpoint T-score for defining osteoporosis among older Chinese population: a framework based on relative fragility fracture risks. Quantitative Imaging Med Surg 12(9):4346\u20134360. https:\/\/doi.org\/10.21037\/qims-22-281","journal-title":"Quantitative Imaging Med Surg"},{"key":"1850_CR235","first-page":"347","volume":"13","author":"S Wanwimolruk","year":"2014","unstructured":"Wanwimolruk S, Prachayasittikul V (2014) Cytochrome P450 enzyme mediated herbal drug interactions (Part 1). EXCLI J 13:347\u2013391","journal-title":"EXCLI J"},{"issue":"1","key":"1850_CR236","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1159\/000541552","volume":"17","author":"N Watanabe","year":"2024","unstructured":"Watanabe N, Harada S, Sato S, Fukuda Y, Tanaka Y, Yanashima K, Sato E, Taniguchi D, Tomizawa Y, Hattori N, Ando M (2024) Chromosomal abnormalities as a predisposition to secondary neurolymphomatosis in patients with diffuse large b-cell lymphoma: a report of two cases and a literature review. Case Rep Oncol 17(1):1201\u20131207. https:\/\/doi.org\/10.1159\/000541552","journal-title":"Case Rep Oncol"},{"issue":"1","key":"1850_CR237","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.bbrc.2017.10.051","volume":"495","author":"J Wei","year":"2018","unstructured":"Wei J, Chen S, Huang C, Guo W, Yang S, Feng B, Chu J (2018) Antagonism of cysteinyl leukot-riene receptor 1 (cysLT1R) by montelukast regulates differentiation of MC3T3-E1 cells under overloaded mechanical environment. Biochem Biophys Res Commun 495(1):995\u20131001. https:\/\/doi.org\/10.1016\/j.bbrc.2017.10.051","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"1850_CR238","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1164\/rccm.201401-0145OC","volume":"190","author":"JM Wells","year":"2014","unstructured":"Wells JM, O\u2019Reilly PJ, Szul T, Sullivan DI, Handley G, Garrett C, McNicholas CM, Roda MA, Miller BE, Tal-Singer R, Gaggar A, Rennard SI, Jackson PL, Blalock JE (2014) An aberrant leukotriene a 4 hydrolase\u2013proline-glycine-proline pathway in the pathogenesis of chronic obstructive pulmonary disease. Am J Respiratory Crit Care Med 190(1):51\u201361. https:\/\/doi.org\/10.1164\/rccm.201401-0145OC","journal-title":"Am J Respiratory Crit Care Med"},{"issue":"1","key":"1850_CR239","doi-asserted-by":"publisher","first-page":"15787","DOI":"10.1038\/srep15787","volume":"5","author":"S Wu","year":"2015","unstructured":"Wu S, Zhu X, Jin Z, Tong X, Zhu L, Hong X, Zhu X, Liu P, Shen W (2015) The protective role of montelukast against intestinal ischemia-reperfusion injury in rats. Sci Rep 5(1):15787. https:\/\/doi.org\/10.1038\/srep15787","journal-title":"Sci Rep"},{"key":"1850_CR240","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2022.174892","volume":"923","author":"Y Wu","year":"2022","unstructured":"Wu Y, Cui C, Bi F, Wu C, Li J, Hou Y, Jing Z, Pan Q, Cao M, Lv L, Li X, Shan H, Zhai X, Zhou Y (2022) Montelukast, cysteinyl leukotriene receptor 1 antagonist, inhibits cardiac fibrosis by activating APJ. Euro J Pharmacol 923:174892. https:\/\/doi.org\/10.1016\/j.ejphar.2022.174892","journal-title":"Euro J Pharmacol"},{"issue":"1","key":"1850_CR241","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3390\/cells8010027","volume":"8","author":"H Xicoy","year":"2019","unstructured":"Xicoy H, Wieringa B, Martens GJM (2019) The role of lipids in parkinson\u2019s disease. Cells 8(1):27. https:\/\/doi.org\/10.3390\/cells8010027","journal-title":"Cells"},{"issue":"3","key":"1850_CR242","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41423-024-01130-4","volume":"21","author":"Y Xin","year":"2024","unstructured":"Xin Y, Xiong S, Zhou L, Lin X (2024) Activation of leukotriene B4 receptor 1 is a prerequisite for complement receptor 3-mediated antifungal responses of neutrophils. Cellular Mole Immunol 21(3):245\u2013259. https:\/\/doi.org\/10.1038\/s41423-024-01130-4","journal-title":"Cellular Mole Immunol"},{"key":"1850_CR243","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/3095624","author":"R Yao","year":"2020","unstructured":"Yao R, Geng Z, Mao X, Bao Y, Guo S, Bao L, Sun J, Gao Y, Xu Y, Guo B, Meng F, Cui X (2020) Tu-teng-cao extract alleviates monosodium urate-induced acute gouty arthritis in rats by inhibiting uric acid and inflammation. Evid-Based Compl Alternative Med. https:\/\/doi.org\/10.1155\/2020\/3095624","journal-title":"Evid-Based Compl Alternative Med"},{"issue":"1","key":"1850_CR244","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1186\/s12974-022-02625-5","volume":"19","author":"AG Yates","year":"2022","unstructured":"Yates AG, Kislitsyna E, Alfonso Martin C, Zhang J, Sewell AL, Goikolea-Vives A, Cai V, Alkhader LF, Skaland A, Hammond B, Dimitrova R, Batalle D, Fernandes C, Edwards AD, Gressens P, Thornton C, Stolp HB (2022) Montelukast reduces grey matter abnormalities and functional deficits in a mouse model of inflammation-induced encephalopathy of prematurity. J Neuroinflammation 19(1):265. https:\/\/doi.org\/10.1186\/s12974-022-02625-5","journal-title":"J Neuroinflammation"},{"issue":"2","key":"1850_CR245","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1093\/jb\/mvu078","volume":"157","author":"T Yokomizo","year":"2015","unstructured":"Yokomizo T (2015) Two distinct leukotriene B4 receptors, BLT1 and BLT2. J Biochem 157(2):65\u201371. https:\/\/doi.org\/10.1093\/jb\/mvu078","journal-title":"J Biochem"},{"issue":"1","key":"1850_CR246","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000081072","volume":"73","author":"G-L Yu","year":"2005","unstructured":"Yu G-L, Wei E-Q, Zhang S-H, Xu H-M, Chu L-S, Zhang W-P, Zhang Q, Chen Z, Mei R-H, Zhao M-H (2005) Montelukast, a cysteinyl leukotriene receptor-1 antagonist, dose- and time-dependently protects against focal cerebral ischemia in mice. Pharmacology 73(1):31\u201340. https:\/\/doi.org\/10.1159\/000081072","journal-title":"Pharmacology"},{"issue":"8","key":"1850_CR247","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3390\/brainsci7080093","volume":"7","author":"J Yue","year":"2017","unstructured":"Yue J, Burke J, Upadhyayula P, Winkler E, Deng H, Robinson C, Pirracchio R, Suen C, Sharma S, Ferguson A, Ngwenya L, Stein M, Manley G, Tarapore P (2017) Selective serotonin reuptake inhibitors for treating neurocognitive and neuropsychiatric disorders following traumatic brain injury: an evaluation of current evidence. Brain Sci 7(8):93. https:\/\/doi.org\/10.3390\/brainsci7080093","journal-title":"Brain Sci"},{"issue":"4","key":"1850_CR248","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1080\/15563650.2017.1284332","volume":"55","author":"S Zakharov","year":"2017","unstructured":"Zakharov S, Kotikova K, Nurieva O, Hlusicka J, Kacer P, Urban P, Vaneckova M, Seidl Z, Diblik P, Kuthan P, Navratil T, Pelclova D (2017) Leukotriene-mediated neuroinflammation, toxic brain damage, and neurodegeneration in acute methanol poisoning. Clin Toxicol 55(4):249\u2013259. https:\/\/doi.org\/10.1080\/15563650.2017.1284332","journal-title":"Clin Toxicol"},{"key":"1850_CR249","doi-asserted-by":"publisher","DOI":"10.7727\/wimj.2015.431","author":"Y Zengin","year":"2016","unstructured":"Zengin Y, \u0130cer M, Gunduz E, Dursun R, Turkcu G, Yuksel H, Ozhasenekler A, Orak M, Guloglu C (2016) Protective effect of montelukast sodium in acute ethyl alcohol-induced hepatic injury in rats. West Indian Med J. https:\/\/doi.org\/10.7727\/wimj.2015.431","journal-title":"West Indian Med J"},{"issue":"2","key":"1850_CR250","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1124\/jpet.113.203604","volume":"346","author":"X-Y Zhang","year":"2013","unstructured":"Zhang X-Y, Wang X-R, Xu D-M, Yu S-Y, Shi Q-J, Zhang L-H, Chen L, Fang S-H, Lu Y-B, Zhang W-P, Wei E-Q (2013) HAMI 3379, a CysLT2 receptor antagonist, attenuates ischemia-like neuronal injury by inhibiting microglial activation. J Pharmacol Exp the 346(2):328\u2013341. https:\/\/doi.org\/10.1124\/jpet.113.203604","journal-title":"J Pharmacol Exp the"},{"key":"1850_CR251","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.neuro.2016.09.022","volume":"57","author":"CT Zhang","year":"2016","unstructured":"Zhang CT, Lin JR, Wu F, Ghosh A, Tang SS, Hu M, Long Y, Sun HB, Hong H (2016) Montelukast ameliorates streptozotocin-induced cognitive impairment and neurotoxicity in mice. NeuroToxicol 57:214\u2013222. https:\/\/doi.org\/10.1016\/j.neuro.2016.09.022","journal-title":"NeuroToxicol"},{"key":"1850_CR252","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuroscience.2011.05.066","volume":"189","author":"CZ Zhao","year":"2011","unstructured":"Zhao CZ, Zhao B, Zhang XY, Huang XQ, Shi WZ, Liu HL, Fang SH, Lu YB, Zhang WP, Tang FD, Wei EQ (2011a) Cysteinyl leukotriene receptor 2 is spatiotemporally involved in neuron injury, astrocytosis and microgliosis after focal cerebral ischemia in rats. Neuroscience 189:1\u201311. https:\/\/doi.org\/10.1016\/j.neuroscience.2011.05.066","journal-title":"Neuroscience"},{"issue":"4","key":"1850_CR253","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1111\/j.2042-7158.2010.01238.x","volume":"63","author":"R Zhao","year":"2011","unstructured":"Zhao R, Shi W-Z, Zhang Y-M, Fang S-H, Wei E-Q (2011b) Montelukast, a cysteinyl leukotriene receptor-1 antagonist, attenuates chronic brain injury after focal cerebral ischaemia in mice and rats. J Pharm Pharmacol 63(4):550\u2013557. https:\/\/doi.org\/10.1111\/j.2042-7158.2010.01238.x","journal-title":"J Pharm Pharmacol"},{"key":"1850_CR254","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.ebiom.2019.05.008","volume":"44","author":"S Zhao","year":"2019","unstructured":"Zhao S, Yao K, Li D, Liu K, Jin G, Yan M, Wu Q, Chen H, Shin SH, Bai R, Wang G, Bode AM, Dong Z, Guo Z, Dong Z (2019) Inhibition of LTA4H by bestatin in human and mouse colorectal cancer. EBioMedicine 44:361\u2013374. https:\/\/doi.org\/10.1016\/j.ebiom.2019.05.008","journal-title":"EBioMedicine"},{"issue":"sup3","key":"1850_CR255","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1080\/21691401.2018.1489264","volume":"46","author":"C Zheng","year":"2018","unstructured":"Zheng C, Shi X (2018) Cysteinyl leukotriene receptor 1 (cysLT1R) regulates osteoclast differentiation and bone resorption. Artif Cells, Nanomed, Biotechnol 46(sup3):64\u201370. https:\/\/doi.org\/10.1080\/21691401.2018.1489264","journal-title":"Artif Cells, Nanomed, Biotechnol"},{"issue":"2","key":"1850_CR256","doi-asserted-by":"publisher","first-page":"93","DOI":"10.21037\/atm-22-6485","volume":"11","author":"G Zhu","year":"2023","unstructured":"Zhu G, Wang L, Han S, Peng H, Tong M, Gu X, Hu H, Wang Y, Lv Z, He X (2023a) Pharmacokinetics and bioequivalence study of montelukast sodium oral soluble film and chewable tablet in healthy Chinese volunteers: randomized trials under fasting and fed conditions. Ann Trans Med 11(2):93\u201393. https:\/\/doi.org\/10.21037\/atm-22-6485","journal-title":"Ann Trans Med"},{"issue":"7","key":"1850_CR257","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e17316","volume":"9","author":"W-X Zhu","year":"2023","unstructured":"Zhu W-X, Xi Y, Li F, Jiao W-E, Li Z-J, Chen S-M, Kong Y-G, Xu Y, Deng Y-Q, Zuo J-J, Tao Z-Z (2023b) Calpeptin may reverse glucocorticoid-resistance of allergic rhinitis associated with cigarette smoke exposure by down-regulating interferon regulatory factor 1. Heliyon 9(7):e17316. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e17316","journal-title":"Heliyon"},{"key":"1850_CR258","doi-asserted-by":"publisher","DOI":"10.3892\/or.2018.6465","author":"A Zovko","year":"2018","unstructured":"Zovko A, Yektaei-Karin E, Salamon D, Nilsson A, Wallvik J, Stenke L (2018) Montelukast, a cysteinyl leukotriene receptor antagonist, inhibits the growth of chronic myeloid leukemia cells through apoptosis. Oncol Rep. https:\/\/doi.org\/10.3892\/or.2018.6465","journal-title":"Oncol Rep"},{"issue":"1","key":"1850_CR259","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1471-2466-13-20","volume":"13","author":"ABS Zubairi","year":"2013","unstructured":"Zubairi ABS, Salahuddin N, Khawaja A, Awan S, Shah AA, Haque AS, Husain SJ, Rao N, Khan JA (2013) A randomized, double-blind, placebo-controlled trial of oral montelukast in acute asthma exacerbation. BMC Pulmonary Med 13(1):20. https:\/\/doi.org\/10.1186\/1471-2466-13-20","journal-title":"BMC Pulmonary Med"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-01850-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-025-01850-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-01850-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T01:14:44Z","timestamp":1757294084000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-025-01850-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,26]]},"references-count":259,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["1850"],"URL":"https:\/\/doi.org\/10.1007\/s10787-025-01850-7","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,26]]},"assertion":[{"value":"13 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors disclose no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}